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Electronic and biological systems both have the ability to sense, respond to, 
and communicate relevant data. This dissertation aims to facilitate communication 
between the two and create bio-hybrid devices that can process the breadths of both 
electronic and biological information. We describe the development of novel methods 
that bridge this bi-directional communication gap through the use of electronically 
and biologically relevant redox molecules for controlled and quantitative information 
transfer. Additionally, we demonstrate that the incorporation of biological 
components onto microelectronic systems can open doors for improved capabilities in 
a variety of fields. 
First, we describe the original use of redox molecules to electronically control 
the activity of an enzyme on a chip. Using biofabrication techniques, we assembled 
HLPT, a fusion protein which generates the quorum sensing molecule autoinducer-2, 
  
on an electrodeposited chitosan film on top of an electrode. This allows the electrode 
to controllably oxidize the enzyme in situ through a redox mediator, acetosyringone. 
We successfully showed that activity decrease and bacterial quorum sensing response 
are proportional to the input charge.  
To engineer bio-electronic communication with cells, we first aimed for better 
characterizing an electronic method for measuring cell response. We engineered 
Escherichia coli (E.coli) cells to respond to autoinducer-2 by producing the β-
galactosidase enzyme. We then investigated an existing electrochemical method for 
detecting β-galactosidase activity by measuring a redox-active product of the 
cleavage of the added substrate molecule PAPG. In our novel findings, the product, 
PAP, was found to be produced at a rate that correlated with the standard 
spectrophotometric method for measuring β-galactosidase, the Miller assay, in both 
whole live and lysed cells. Conversely, to translate electronic signals to something 
cells can understand, we used pyocyanin, a redox drug which oxidizes the E.coli 
SoxR protein and allows transcription from the soxS promoter. We utilized electronic 
control of ferricyanide, an electron acceptor, to amplify the production of a reporter 
from soxS. With this novel method, we show that production of reporter depends on 
the frequency and amplitude of electronic signals, and investigate the method’s 
metabolic effects. Overall, the work in this dissertation makes strides towards the 
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Chapter 1: Motivation and Introduction 
This chapter provides a brief introduction to the fields and concepts that span 
the whole dissertation, and the motivation and research context for the work.  
Chapters 2-4 can each stand alone and provides their own abstracts, relevant 
background, methodology sections, results and discussion, and conclusions. Overall 
summary, contributions, and future work are detailed in Chapter 5.  
Motivation 
Efficient, programmable, and meaningful communication and information 
transfer between biology and electronics is a highly sought-after functionality with 
many applications in clinical and research settings. These applications range from 
biosensors for detection of biomolecules in blood samples, implantable devices, 
devices for study of cellular signaling cascades and function, to autonomous cell-on-
chip devices with remote sensing and control.  If we are to make the best predictions 
and analyses of diseases as well as study and manipulate the biological environment, 
it is necessary to explore and improve upon both aspects of this bi-directional bio-
electronic communication path.  
While there are a variety of examples and goals of the biology-to-electronics 
communication route, one of the overarching objectives is to be able to gather as 
much biological information as possible and to best interpret it using electronics. 
Biology is expert at detecting biomolecules (be it through enzymes or cells) that are 
undetectable otherwise, and translation of this information to electronic form allows 





with easy storage. Better translation of biological to electronic information would 
allow for more efficient and relevant diagnoses and studies, as would better 
understanding and interpretation of the phenomena. The additional possibility of real-
time in situ measurements that electronic sensing presents greatly increases the 
technology’s benefits and desirability.   
Conversely, granting cells the ability to readily interpret signals originating 
from electronics into pre-programmed functions would allow us to manipulate and 
study cellular behavior with an unprecedented degree of precision. For this, we would 
need direct control of cell behavior that can elicit a desired amplitude of response at a 
desired time and at a pre-programmed location. On top of their programmability, 
electronic devices can sense electric, magnetic, thermal, and acoustic changes with 
speed and precision that biological entities cannot. Translating this information to 
cells would allow for a much wider range of studies and behaviors. In addition to 
cells, wiring functional proteins to respond to electronic signals in meaningful ways 
would further biochemical studies where precise control cannot otherwise be easily 
achieved. 
Thus, it can be seen why a bridging of the communication gap between 
biology and electronics would benefit advancement in a variety of applications and 
fields. This gap derives from the fact that biological entities communicate with 
proteins, small molecules, and ions, whereas electronics does so with electrons. 
Redox molecules seem to fit the bill as a candidate for intermediate translators 
because they are electron carriers that can interact with an electrode and can also be 





redox molecules’ interactions with both cells and electronics and our knowledge of 
what governs those interactions allows us to use them for electrically-driven enzyme-
activity attenuation, electrochemical cell-based gene reporter analysis, and as live-cell 
gene activators.  
Research goals 
The overarching aim of this work is to facilitate meaningful information transfer and 
communication between biology (cells and proteins) and electronics (electrodes). In 
order to accomplish this, we aimed to work on three different developments:  
1. A method to use electronic signals to attenuate enzyme activity, described in 
Chapter 2 
2. An analysis to enhance use of a method for electronic measurement of 
reporter protein expression from live cells, described in Chapter 3 
3. A method to allow electronic signals to modulate gene expression, described 
in Chapter 4 
All the above aims use various redox molecules to translate either the electronic 
signals to biological or vice versa. 
 
Research background 
Redox molecules and electrochemistry 
 In this work, it is our ambition to utilize redox molecules as the intermediaries 
between biology and electronics, as they can interact in meaningful ways with cells 





which are processes of gain or loss of electrons, respectively - as shown in Figure 1.1 
a. This loss or gain of electrons depends on the standard potential of the molecules 
interacting and on the states of the molecules. The standard electric potential (E0) of a 
molecule is a number that can be used to determine whether it will draw electrons 
from or donate electrons to another molecule with a known E0. When two molecules 
interact, typically the one with a more positive E0 will draw electrons from a 
molecule with a more negative one – as demonstrated in Figure 1.1 b. For this to 
work, the molecules have to also be in the correct form (i.e. have the electrons to 
donate in the first place or have “space” to accept electrons) – in the reduced form to 
donate electrons, and in the oxidized form to accept them. The molecules also have to 






Figure 1.1: Redox principles. a, The participants and interactions in a typical redox 
reaction (image taken from 
http://academic.pgcc.edu/~kroberts/Lecture/Chapter%205/redox.html). b, A potential profile 
based on E0 vs. an Ag/AgCl electrode of several biologically-relevant molecules. In an 
interaction, electron donors possess a more negative E0 and acceptors a more positive.  
 
An electrode can be biased at a potential such that it interacts with the redox 
molecule in a similar manner – donating or drawing electrons. The amount of 
electrons that are exchanged at the electrode is measured as the current at the device 





measured at a working electrode, is balanced for the solution as a whole at the counter 
electrode, and is compared to the current at the reference electrode where the 
electrochemical reactions are well-characterized - example of a setup can be seen in 
Figure 1.2 a 2. In this way, a three electrode system can be used to not only precisely 
measure the amount of a redox molecule, but can give information as to the relative 
amounts of the forms (oxidized or reduced) and, importantly, can be used to change a 
molecule’s form by applying the relevant potential.  
 
Figure 1.2: Electrochemical setup and CV analysis. a, Schematic of the general 
electrochemical setup that is used in the experiments in this work, with the solution of interest 
containing mediator and/or cells. b, A cyclic voltammogram of 40μM pyocyanin, with an 





oxidation. At an electrode biased at -0.4V, the pyocyanin will be reduced and the current will 
measure the amount of oxidized pyocyanin (which will tend to the negative as oxidized 
pyocyanin is depleted). At an electrode biased at +0.05V the pyocyanin will be oxidized and 
the current will measure the amount of reduced pyocyanin (which will tend to the positive as 
reduced pyocyanin is depleted). 
 
Electrochemistry techniques that are relevant to this dissertation include cyclic 
voltammetry, chronoamperometry, and bulk electrolysis. Cyclic voltammetry (CV) 
involves the cycling of the voltage at the working electrode between two limits at a 
specified speed and measuring the resulting current. CV is useful for investigating the 
solution of interest for redox-active components, where peaks or increases in current 
can be measured and compared to controls. CV’s allow for the finding of the E0 as 
well as the reduction and oxidation currents of redox molecules in the given system. 
Additionally, the calculated current or charge can allow one to measure the 
concentration of the redox analyte. In this dissertation, we used CV’s to both 
determine the oxidation and reduction currents for bulk electrolysis and to construct a 
charge vs. analyte concentration graph for further measurement. Determining charge, 
which is current over time, from a CV and correlating that to analyte concentrations 
allows more robust measurements when the solution conditions may change slightly 
and result in a change in the potential of the peak current.  
Chronoamperometry (CA) involves the selection of one or more potentials, 
and their application to the solution for set amounts of time. The readout of a CA is 
again the current. CA’s applied for short amounts of time can be used to measure the 





CAs applied for longer periods of time, such as in bulk electrolysis, can be used to 
change the redox state of a molecule in solution. For bulk electrolysis, the counter and 
working electrodes must be separated by a salt bridge (this allows only charge to pass 
through between the two compartments). Additionally, stirring and a large electrode 
surface area speed up the process. In this dissertation, we use bulk electrolysis to 
change back and forth the redox state of redox molecules. 
As an example, the redox molecule pyocyanin has an E0 around -0.34 vs. an 
Ag/AgCl electrode, with the exact value depending on the conditions of the system3. 
In order to determine the E0 for a setup, CV can be used. If the E0 of a redox molecule 
of interest lies within that potential range, one will see reduction and/or oxidation 
peaks as the molecule changes forms (this of course depends on the reversibility of 
the reactions). For pyocyanin we can see in Figure 1.2 b that the E0 of a 40μM 
solution was around -0.22V in the given conditions. When the potential was more 
negative than this number, reduction of pyocyanin takes place (upper right inset), and 
when the potential was more positive oxidation takes place (lower left inset).  
 
Electrochemical effects on cells 
An important concern when designing a system where electricity is going to 
be used in the vicinity of cells is the negative effect that this current may have on the 
cells or proteins. To our knowledge, the potential range in which we worked has not 
been shown to cause significant cellular damage, by itself or through the generation 
of byproducts, ions, or reactive oxygen species in significant quantities – especially 





were run in the 0.6 to -0.5V range. In either LB, defined minimal media, or phosphate 
buffer of pH ~7, we have not observed the formation of significant amounts of the 
above-mentioned species.  
Hydrogen peroxide formation (O2 + 2H+ + 2e- ↔ H2O2) occurs in the 
presence of oxygen around -0.2V. This could have potentially affected our system 
when we performed bulk electrolysis at -0.3V, but because we were working in an 
anaerobic system there was minimal oxygen for the hydrogen peroxide to form from. 
Around +0.6V the reverse reaction occurs (H2O2 ↔ O2 + 2H+ + 2e-), but we did not 
stay at the +0.6V potential for more than a few seconds when performing cyclic 
voltammetry and therefore saw no problems2,4. It is certainly hard to say what exactly 
happens in the system because, for example, the precise content of LB media is 
unknown and there could be possible unforeseen cellular byproducts- but thorough 
testing gave us an idea of what phenomena were taking place. More relevant in-depth 
information on redox molecules in biological context is presented in the Introductions 
of the following chapters.  
 
Biochips and bio-hybrid devices 
 Part of the larger aim of this work is to build novel bio-hybrid devices and to 
advance their overall functionality. This is also the aim of the Maryland Biochip 
Collaborative, whose insights and work inspired much of what we accomplished here. 
Bio-hybrid devices, as described here, are a class of devices that contain living and 
non-living components and usually involve an intimate interaction between the two 





of each to accomplish or enhance either a bio-measurement or bio-actuation goal. For 
example, bio-hybrid devices involving proteins immobilized on surfaces can allow 
for less bio-component use, faster process, and more precise measurements whereas 
immobilized cells allow for more fine-tuned environmental control and easier cell 
tracking5-9.  
 
Synthetic biology  
Synthetic biology is a discipline that aims to modulate cells by engineering novel 
functionality through the rewiring of existing or the engineering of novel genetic circuits. 
It focuses on rational design of constructs from standardized parts (which would ideally 
work similarly in a variety of cellular environments) and provides a different perspective 
than traditional genetic engineering. Substantial progress has been achieved in many 
areas of research, including biomaterials, chemicals, energy production, bio-computation, 
and biosensors10-17. Additionally, studies have demonstrated the potential use of synthetic 
biology in biomedical applications such as drug development, tissue engineering, and 
cancer therapeutics18-23. Synthetic biology constructs have even been proposed for 
recycling and generation of valuable materials for space travel24.  
This work focuses on utilizing the tools of synthetic biology and on improving 
the capabilities of engineered constructs by allowing easier genetic response 
measurement and easing the load of engineered factors in the cells. Specifically – in 
Chapter 3 we show that the reporter protein β-galactosidase can be quantitatively 
measured in live cells by electrochemical means in a manner comparable to the standard 
Miller Assay. The enzyme is a commonly-used reporter in the synthetic biology 





goes well with the trend towards real-time miniaturized measurements in the community. 
In Chapter 4, we introduce a novel method for using electrochemical signals to turn on 
specific gene expression in a programmable manner. This also is an advancement that 
allows for the tuning production of a desired gene without the need for extra “clock” or 
“oscillator” genetic elements so often found in systems engineered for these purposes. 
We thus lessen the genetic burden of the control elements inside the engineered cells 
without sacrificing response capabilities. This development also works well with the 
trend towards miniaturization and may greatly enhance capabilities of engineered cell-




















Chapter 2: Electronic modulation of biochemical signal generation 
 
The majority of this section is adapted from the following publication: 
Gordonov, T et al. “Electronic modulation of biochemical signal generation”. Nat 
Nanotechnol. 2014 Aug;9(8):605-10 with permission25. 
Chapter abstract 
The goal of this work is to use electrical signals to assemble and “tune” an 
enzymatic pathway on a gold electrode chip, thereby creating a “programmable” 
biohybrid device containing both biological and electronic components. Our 
hypothesis is that the electric signals control both the amount of assembled enzymes 
and their activity, the latter by oxidation through a diffusible redox mediator. Our 
desire is that this process be stable, predictable, and that a generalized method for 
controlling biological activity is obtained. 
Introduction 
 
Microelectronic devices embedded with biological components often facilitate 
the interrogation of biology26,27 as opposed to controlling biological function.  
Patterned protein and cell assemblies, for example, offer the potential for “in vitro” 
metabolic engineering28-31, wherein coordinated biochemical pathways enable on-chip 
characterization of cell metabolism and possibly control of cell-based systems32. 
Considered among the animal- or human-on-a-chip technologies33, such devices are 





new biofabrication methodologies that expand bio-device interconnectivity36 – 
enabling new modes of device assembly and of communication. Here we demonstrate 
electrically-mediated assembly, interrogation, and control of a multi-domain fusion 
protein that produces a bacterial signaling molecule. The biological system is 
electrically “tuned” using a natural redox molecule and its biochemical response is 
shown to provide the signaling cues to drive bacterial population behavior. We show 
that the biochemical output correlates with the electric input charge – suggesting the 
potential for employing electrical inputs to control complex on-chip biological 
processes.  
 As pictured in Fig. 2.1 a, the biohybrid device assembly process is 
electrically guided via electrodeposition37,38. As our model enzyme, the multi-domain 
fusion protein HLPT32 (Fig. 2.1 b) is covalently grafted onto the chitosan scaffold 
electrodeposited on a gold electrode chip (Fig. 2.1 c). In this way the chitosan film 
serves as a template for protein incorporation onto the device surface. HLPT consists 
of an N-terminal pentahistidine tag and the bacterial enzymes LuxS and Pfs, which 
are the two terminal synthases of bacterial autoinducer-2 (AI-2). This quorum sensing 
(QS) signal molecule is normally secreted from cells to mediate a transition from 
individual cell to collective behavior within bacterial populations, and promotes the 
establishment of biofilms39-41, among other phenotypes. In our work, we use electric 
signals to thus mediate bacterial responses. HLPT also contains a C-terminal 
pentatyrosine tag that allows covalent attachment to chitosan’s primary amines via 
the enzyme tyrosinase42. These biofabrication assembly methods have proven reliable 







Figure 2.1: Schematic of biohybrid device controlled by electronic signals. a, 
Schematic diagram representing the biohybrid device receiving both chemical (enzyme 
reaction precursor) and electronic inputs, and through biochemical intermediates, translating 
them to both electrochemical signals and biological cells response. b,  A representation of the 
components of the multi-domain fusion protein (HLPT) used in this study. c, The concept of 
the experiments is that by varying the electronic inputs through the electrodes on which 
HLPT is attached, we can vary the attenuation of HLPT activity and thus affect the 
electrochemical and biological responses in proportion to the input. Purple rectangles 
represent the silicon wafer, gold rectangles are patterned gold electrodes, semi-transparent 
turquoise rectangles are the biocompatible chitosan scaffold. Hcy is homocysteine, AI-2 is 
autoinducer-2. His stands for histidine and Tyr for tyrosine. LuxS and Pfs are enzymes 





Materials and methods 
Chemicals and Reagents 
DL-homocysteine, potassium hexachloroiridate(IV) (K2IrCl6), potassium 
hexachloroiridate(III) (K3IrCl6), 3′,5′-dimethoxy-4′-hydroxyacetophenone 
(acetosyringone, AS), S-(5′-adenosyl)-L-homocysteine (SAH), CBZ-Gln-Gly, 
glutathione (reduced form), phosphate buffered saline (PBS) tablets at pH 7.4, Trizma 
hydrochloride, chitosan of medium molecular weight, parafolmaldehyde powder, β-
galactosidase enzyme from E.coli grade VIII, and tyrosinase enzyme from mushroom 
were purchased from Sigma Aldrich. Ellman’s reagent (also known as DTNB or 5-(3-
Carboxy-4-nitrophenyl) disulfanyl-2-nitrobenzoic acid) is from Uptima, Interchim. 
Tris-HCl pH 8.0 was from Quality Biological Inc. Sodium acetate, ampicillin sodium 
salt (Ap), monobasic and dibasic sodium phosphates, trichloroacetic acid, and LB 
Broth (Miller) were from Fischer Scientific. Kanamycin (Km) was from Genlantis. 
Calcium Chloride was from J.T.Baker. FeCl3 was from Arcos Organics. DyLight 
antibody labeling kit, 405 (Thermo Fischer Scientific Inc.) was used for labeling the 
HLPT protein. Red fluorescent chitosan was labeled with 5-(and-6)-
carboxyrhodamine 6G succinimidyl ester (Invitrogen) as per Wu et al. 44 Chelex-100 
resin was from Bio-Rad. Microbial transglutaminase (mTG) was from Ajinomoto 
(Chicago, IL). 
 
Biohybrid Device Assembly 
A thin layer of chitosan was deposited on a gold-coated silicon chip (electrode 





electrode (anode) into a 0.8 % chitosan solution (prepared as described45) and 
applying a current for 2.5 minutes at 4 A/m2. After rinsing the chitosan film with 
distilled water, tyrosinase at 300U/µL was mixed with tyrosine-tagged HLPT (10 µM 
in PBS) and incubated at RT for 1 hour with the chitosan-coated electrodes. 
Afterwards, each electrode was briefly rinsed with PBS and kept in PBS until use. 
After appropriate treatments (see below) two similarly-treated electrodes, facing away 
from each other, were diagonally immersed in a 300 µl solution of 1 mM SAH in 0.1 
M pH 7 Phosphate Buffer in a standard semi-micro cuvette (Cole Parmer). The 
cuvette was stoppered and incubated at 37 °C with 100rpm shaking for the indicated 
amount of time to let the enzymatic reaction take place (3-3.5 hours). See Figure 2.2 
for setup.  
 
On-Chip Biohybrid Device Electrical Attenuation 
For in situ attenuation with acetosyringone, the gold chip with HLPT 
(assembled as above) was used as the working electrode in a 3 electrode system with 
a 0.5 mm diameter, 4 cm-long platinum counter electrode (Alfa Aesar), and Ag/AgCl 
reference electrode (BASi). These were put in a 250 µM AS solution and the working 
electrode biased at +0.55 V using a CH Instruments workstation (CHI 6273c) for the 
designated amount of time (10-1000 sec). The chip was then rinsed gently with PBS, 








Electrochemical Homocysteine Detection 
For measuring the homocysteine generated from an on-chip HLPT, the 
reaction solution is removed at the end of the incubation with SAH, allowing Hcy 
measurement. Cyclic voltammetry was used to detect homocysteine. A three 
electrode setup was used, with a 2 mm diameter gold working electrode (CH 
Instruments) and counter and reference electrodes same as in the attenuation method 
above. The potential was swept from 0 V to +0.7 V and back at 50 mV/sec 
(approximately 28 sec). Electrodes were cleaned briefly with Piranha solution (70 % 
H2SO4 and 30 % H2O2) before start of experiment. Between every measurement the 
working electrode was polished for 1 min with 0.05 micron alumina powder on a felt 
polishing pad (CH Instruments) and rinsed with distilled water, except during real-
time measurement experiments. Integration of the output current yields the output 
charge in Coulombs (Q=∫idt). In our experiments, the total accumulated charge at 
+0.7V is recorded and used as a measure of homocysteine.  
 
Electrode Fabrication 
A 4 inch silicon wafer (100 P/Doped, 1-100 ohm/cm resistivity with thermally 
grown oxide, from University Wafers) was coated by thermal evaporation with 20 nm 
of chromium (Cr) and 120 nm of gold (Au). Standard photolithography and 
subsequent etching of Cr and Au were performed to define electrodes of 7 mm 
diameter (Fig. 2.2). Each circular electrode is connected to a contact pad via a thin 





microdicing saw. Fabrication steps were performed at the University of Maryland 
Nanocenter.  
 
Setup for in situ Oxidation and Biohybrid Device Attenuation 
Once the biohybrid device is assembled (see below), in situ attenuation using 
AS was achieved using the setup seen in Fig. 2.2 c. A 10 mL beaker filled with the 
mediator solution was positioned so that the electrodes were all immersed in the 
solution.  
 
Setup for Biohybrid Device Enzymatic Reaction 
For incubation of the assembled biohybrid device with the SAH substrate for 
subsequent Hcy and AI-2 generation, two chips, facing outward, were inserted 
diagonally and incubated in standard polystyrene semi-micro cuvettes (Cole Parmer) 
(Fig. 2.2 d). The chip was immersed so that the liquid (300 µl) reached to the top of 






Figure 2.2: Chip and test system setup. a, The AutoCAD drawing and dimensions of 
one electrode for the mask used for fabrication of electrodes used in the biohybrid device 
assembly. b,  A photo of the electrode chip on which HLPT was immobilized. c, A diagram 
of the setup used for in situ attenuation of the biohybrid device, in this case with 250 µM 
AS(R).  d, A photo taken of the setup in which two electrodes, inserted diagonally and facing 
out, were incubated in 300µl of the substrate to allow enzymatic reaction (electrodes in photo 








Electrodeposition of Chitosan Film and Enzymatic Assembly of HLPT  
The thin film of the pH-responsive polysaccharide chitosan was 
electrodeposited onto the chip (Fig. 2.3 a,b)45, 46. Mushroom-derived tyrosinase was 
then used to oxidize HLPT’s pentatyrosine tag, creating an active quinone, which 
grafts onto chitosan’s primary amines via a Michael’s adduct (Fig. 2.3 c). These 
methods have proven reliable in retaining enzymatic activity and in providing an even 
protein coating 29,47, 43.   
 
Figure 2.3: Biofabrication: Chitosan electrodeposition and tyrosinase-based 
enzyme conjugation. Middle schematic represents the biofabrication processes used in this 





chitosan and its’ amine groups below and above its pKa of 6.3. b, Immersion of a negatively-
biased electrode into a solution of chitosan results in a pH gradient (higher pH at the surface) 
that promotes the electrodeposition of a chitosan film on the surface as well as the exposure 
of amine groups. c, Tyrosinase-mediated conversion of tyrosine residues to o-quinones results 
in the covalent attachment of HLPT protein to chitosan’s amines.  
 
Ellman’s method: Homocysteine Measurement 
The “Ellman’s Test” was done according to manufacturer’s instruction 
(Uptima, Interchim). Briefly, a DTNB stock solution is made with 50 mM sodium 
acetate and 2 mM DTNB in water. The Tris buffer is 1 M Tris at pH 8.0. Per each 1 
mL total volume, 50 µL of the DTNB stock, 100 µL of the Tris solution, and 850 µL 
total distilled water and sample solution are added. In some experiments, these were 
scaled down by a factor of 10. DL- homocysteine standard solution was prepared in 
0.1 M phosphate buffer pH 7.0.  The contents are mixed and incubated at room 
temperature for 5 minutes. Optical absorbance is then read at 412 nm and the SH 
content is calculated by dividing the OD at 412 nm by 13600 M-1cm-1 to get the 
molarity in the assay, and multiplied by the total volume/sample volume ratio for the 
estimated original concentration.  
 
AI-2 Reporter Cells and Cell Culture 
Cells used for detection of AI-2 from HLPT were CT104 Escherichia coli (E. 
coli) (W3110-derived luxS lsrFG double mutant strain from lab stock) with the 





with T7RPol, Apr) 48 and pET200-EBFP2 (pET200 derivative, containing EBFP2, 
Kmr, from lab stocks). Cells were inoculated at 2 % from an LB overnight culture and 
Ampicillin and Kanamycin were added at 50 µg/mL. After an OD600 of about 0.4 
was reached, cells were spun down in 300 µL volumes at 8000 rpm for 3 minutes, 
and re-suspended in PBS, 10 % LB and HLPT reaction mixture with homocysteine 
and AI-2. Reaction mixture, when incubated with the cells, was therefore at 90 % of 
original concentration or, in the cases where the concentration was higher than 50 
µM, at 10%. All compared samples were similarly diluted. The cells were incubated 
for 4 hours at 37 °C at 250 rpm with aeration. After this, the cells were fixed with 2% 
paraformaldehyde in PBS for 30 minutes at room temperature and stored in 4 °C until 
measurement. Blue DAPI fluorescence was recorded by FACS (FACSARIA, BD 
Biosciences). To ensure sample consistency, 50,000 cells were collected for each 
sample and consistently gated by forward scatter (FSC) and side scatter (SSC). The 
mean blue DAPI fluorescence levels are based on the means from one or two 
different samples. 
 
Enzymatic Activity Calculations 
Enzyme activity was calculated in either nmol HCY/(min*mg protein) or as 
nmol HCY/(min*cm2 of electrode). For both cases, the concentration of 
homocysteine measured in µM was calculated from the equations from the standard 
graph in Fig. 2.4 d.  This concentration was then used to calculate the nanomolar 





recorded time of the reaction. The amount of protein was known in the solution-based 
experiments, as was the surface area of the electrodes in cm2. 
 
Oxidation with Strong Oxidant Ir(IV): Solution-Based Attenuation 
Enzymes (Pfs, LuxS, or HLPT) were diluted in phosphate buffer pH 7.0 to the 
indicated concentration. Mediators were added and the samples incubated at room 
temperature for the indicated times. Solutions were then filtered using a 0.5 mL 
centrifugal filter (MWCO: 10 k, Millipore) and washed three times (5 minutes at 
14,000 g) with 0.5 mL of phosphate buffer to wash out the mediator. The substrate 
used for HLPT or Pfs was 1 mM SAH. For LuxS the substrate, SRH, was produced 
by boiling 1 mM SAH in HCl39. The enzyme and substrate were reacted in the 
conditions indicated. For Pfs activity, the solution was incubated with both the 
attenuated Pfs and un-attenuated LuxS in equimolar concentrations, after which 
homocysteine was measured. The amount of generated homocysteine was detected 
using Ellman’s reagent and/or via electrochemical method (see above). Absorbance 
measurements were performed with the addition of one of the enzymes to Ir(III) or 
Ir(IV) solutions.  
 
Ellman’s Method for Protein Sulfhydryl Measurement 
The Ellman’s Test was used for measuring accessible sulfhydryls present on 
proteins. The test was done according to manufacturer’s instruction (Uptima, 
Interchim). The solutions were prepared the same as in the “Ellman’s method” 





testing solution, all components were scaled down by a factor of 10 so that a total of 
100 µl was tested in a 96-well clear plate. First, the proteins were treated with AS(O) 
or AS(R) for 500 sec at a ratio of 0.1 µM protein: 1 µM AS in PBS. These were then 
filtered as described in “solution-based attenuation” in above. Treated proteins were 
added at the indicated concentrations to PBS, 5 µl DTNB and 10 µl Tris. The 
contents were mixed and incubated at room temperature for 5 minutes. Optical 
absorbance was read at 412 nm and the SH content is calculated by dividing the OD 
at 412 nm by 13600 M-1cm-1 to get the molarity in the assay, and multiplied by the 
total volume/sample volume ratio for the estimated original concentration.  
 
Protein Preparation for Electron Paramagnetic Resonance (EPR) 
The protein HLPT was used at a final concentration of 20 µM. Samples were 
treated with Ir(IV) at 300 µM or AS at 200 µM as described above in “solution-based 
attenuation”. For filtering and washing out the Ir and AS, Chelex 100 resin-treated 
deionized water was used. The Chelex treatment of water or PBS (which removes 
copper, iron, and other heavy metals) was done according to manufacturer’s 
instructions – 2.5 grams of the resin was mixed with 50mL of either MilliQ-filtered 




CPH hydrochloride (known as 1-Hydroxy-3-carboxy-2,2,5,5-





final concentration of 1 mM was used for all samples, for a 50 µL total sample. 
Measurements were taken at 2 minutes and 5 minutes after CPH addition. Also, a 16-
run average was done for each sample. The intensities were normalized and averaged. 
All EPR measurements were carried out using a Bruker EMX ESR spectrometer 
(Billerica, MA) at ambient temperature. The settings were as follows: 1 G field 
modulation, 100 G scan range, and 20 mW microwave power, 80 s/scan for single 
scans, 40s/scan for 16-scan runs.  
 
Inductively Coupled Plasma Optical Emission Spectrometry (ICP-EOS) 
ICP EOS experiments were run on a Perkin Elmer Optima 4300DV. Samples 
were 200 µg/ml of HLPT diluted into diH20 from 2.5 mg/ml in PBS (5 mL total). 
Samples of 2.33 mg/ml HLPT were incubated with 1.33 mM Ir(IV) or AS(O) for 1 
hour and filtered as indicated above.  
 
Bulk Acetosyringone Electrical Oxidation 
Acetosyringone was dissolved in pH 7.0 phosphate buffer. The solution, in the 
indicated concentration, was put in a 10 mL beaker. Nitrogen was continuously 
bubbled through the solution to prevent oxygen interference. A three electrode system 
was set up and immersed in the solution - gold-coated silicon working electrode (area 
about 2 cm2), platinum foil counter electrode with a glass salt bridge, and silver/silver 
chloride reference electrode.  The working electrode was biased at +0.55 V and the 





1-2 hours). HLPT was then treated with the AS as in “solution-based attenuation” 
above. 
 
On-chip HLPT attenuation: Control Reactions 
Control reactions with non-oxidizing voltage (+0.22 V) in AS solution, as 
well as the oxidizing voltage (+0.55 V) in a solution of phosphate buffer alone were 
run and showed significantly lower currents than the experimental samples 
(Supplementary Fig. S2.4 a). Enzymatic activities (as calculated in Supplementary 
Information and seen in Supplementary Fig. S2.4 b) were correspondingly unaffected.  
 
Real Time HLPT Activity Measurement On-Chip 
For real time in situ measurements, the same general procedure for device 
assembly, in situ attenuation, and homocysteine electrochemical measurement as 
previously were followed. In these experiments though, CV’s were taken using a CHI 
Multiplexer from 8 samples one after the other, 3 minutes apart. A bare chlorinated 
Ag wire was used as the reference electrode, and electrodes remained in the test 
solution throughout, which was kept at room temperature.  
 
Statistical Analysis 
Statistical analysis with calculation of p-values was performed by using two-
tailed, unequal variance Student t-tests. * indicates p < 0.05, ** p < 0.01, *** p < 






Results and discussion 
After assembly, the desired biohybrid device will modulate the activity of 
HLPT for the guided synthesis of AI-2 and a byproduct, homocysteine (Hcy) (made 
in a 1:1 stoichiometric ratio). On-chip enzyme activity is assayed via three modalities 
- optically, electrochemically and biologically. Our experiments are carried out at 
physiologically relevant concentrations and importantly, our methods are linear in 
these ranges including a near real-time electrochemical method for Hcy. Applications 
that require real-time assessment and with no sampling (direct in situ measurement) 
may thus be feasible (Supplementary Fig. S2.5). 
Homocysteine (Hcy) can be measured optically (Ellman’s assay based on SH 
groups49) or electrochemically by sulfhydryl oxidation at a gold electrode (as 
discussed in Methods). A linear relationship between these methods (Fig. 2.4 a) 
yields quantification of biochemical flux through HLPT (Fig. 2.4 b) and allows 
measurement of HLPT activity over time without sample consumption (Fig. 2.7 c). 
AI-2 produced in a 1:1 ratio to Hcy assayed with a cell-based method is linearly 






Figure 2.4: Detection of Hcy and AI-2. a, Comparison of the electrochemical detection 
method used in this chapter to the standard Ellman’s assay. The Pearson correlation 
coefficient for linearity was calculated between the charge transferred and the Ellman’s 
absorbance value, yielding an R2 value of 0.98. Seven measurements were taken for each 
averaged data point. b, Graph of the same values as in a of the electrochemical data with the 
axes reversed. The fitted line was used throughout the chapter to convert charge to 
homocysteine concentration, and the R2 value shown is the Pearson correlation coefficient for 
linearity. c, Different concentrations of HLPT were reacted with 1 mM SAH over the course 
of 4 hours at 37 °C. Electrochemical measurements were taken throughout. The fitted 
polynomial curves are used to convey trends.  d, The products from the reactions in c, after 
the final time-point, were added to AI-2 reporter cells at a 1:10 dilution, whose average blue 





between the homocysteine measured and the cell fluorescence response was calculated and 
gave an R2 value of 0.95 (it is not for the HCy vs HLPT relationship). HLPT is the fusion 
enzyme under study. 
 
HLPT oxidation can be mediated in several ways. Our initial studies 
employed chemical oxidation via powerful protein oxidant K2IrCl6 (iridium, denoted 
Ir(IV))50. Our results indicate that oxidized iridium and not its reduced form 
(controls) decreased HLPT activity in a predictable concentration- and time-
dependent manner (Fig. 2.5, Supplementary Fig. S2.1).  
 
Figure 2.5: HLPT activity attenuation by strong oxidant Ir(IV) in solution. a, Proposed 
reaction of Ir(IV) with HLPT in solution, resulting in oxidation of HLPT and attenuation of 





becomes reduced to Ir(III), losing its brownish color. c, Spectrophotometric measurements of 
Ir(IV) or Ir(III) after reacting with HLPT, Pfs, or LuxS for 40 minutes. All three proteins turn 
Ir(IV) to Ir(III) color. d, Activity of HLPT remaining after treatment of HLPT with different 
Ir(IV) amounts. All measurements done in triplicate and error bars indicate s.d. P values for 
samples were calculated using student’s t-test (two tailed, unequal variance), compared to the 
active HLPT positive control. ** indicates p < 0.01, *** p < 0.001, **** p < 0.0001. Ir(III) 
and Ir(IV) are the reduced and oxidized forms of the redox mediator IrCl6. HLPT is the fusion 
protein under study, and Pfs and LuxS are the two enzymes making up HLPT. 
 
We predicted the reaction in Fig. 2.5 a to take place as the Ir(IV) oxidized 
HLPT, turning to Ir(III) in the process. Ir(IV) has a characteristic brownish color 
which diminishes as it is reduced to Ir(III) (Fig. 2.5 b). Incubating HLPT (as well as 
its constituents Pfs and LuxS, separately) with a solution of Ir(IV) shows a fall in 
absorbance, measured over the course of an hour (Fig. 2.5 c). In Fig. 2.5 d 1.5 µM 
HLPT was incubated for 1 hour with different Ir(IV) amounts. Hcy measurements 
were taken after filtering and further incubation with 1 mM SAH substrate for 3 hours 
at 37 °C. 
Next, in order to test for electric actuation, we selected the natural plant-based 
redox mediator acetosyringone (AS) (E0 of +0.5 V vs. Ag/AgCl). AS is generated 
during the innate plant immune response to pathogens, and then consumed in an 
oxidative burst 51. It normally exists biologically in a reduced state (AS(R)). As can 
be seen in Fig. 2.6 b, we observed electric oxidation of AS by the simple evolution of 






We next investigated whether electrically-oxidized AS could oxidize HLPT 
(Fig. 2.6 a), and the nature of that oxidation. LuxS has a divalent cation (Zn2+, Fe2+) at 
its active site, which could be a target for oxidation and attenuation of activity. 
Alternatively, sulfhydryl residues are more suitable targets for a generalized 
approach. AS(O) was added to HLPT, as well as LuxS and Pfs, after which the 
oxidation status of the protein was measured. Our results indicating ~4-fold reduction 
in –SH groups (Fig. 2.6 d) showed that AS(O) oxidized vulnerable sulfhydryl 
residues on all three proteins.  These results are supported by electron paramagnetic 
resonance (EPR) spectroscopy, which yields a protein’s more general oxidation state. 
That is, to detect general oxidation, we employed EPR probe, CPH (1-Hydroxy-3-
carboxy-2,2,5,5-tetramethylpyrrolidine - HCl), which is oxidized by an oxidized 
HLPT so that its radical is revealed and detected. We measured a 2.5 fold increase in 
CPH radical from solutions where HLPT was treated with AS(O) (Fig. 2.6 c). 
Additionally, using inductively coupled plasma optical emission spectroscopy (ICP-
EOS), we found Zn2+ was unaffected (Supplementary Fig. S2.2 b).  In sum, our 
results demonstrate that HLPT activity is attenuated by oxidation of its sulfhydryl 
residues and not by oxidation of the active-site cation. Moreover, these results support 
the notion that on-chip reaction activity could be controlled by exposure to oxidized 






Figure 2.6: Electronically-driven HLPT attenuation by natural mediator AS.  
a, Schematic of the electrochemical oxidation of AS(R) in solution is followed by its addition 
to HLPT, where it oxidizes and attenuates HLPT activity and is reduced back to AS(R) in the 
process. b,  Spectrophotometric measurements of AS(R) and AS(O) – as AS is oxidized, it 
turns a brownish-orange color, detectable at 490nm. c, Oxidation of HLPT by AS(O) can be 
detected with the EPR probe CPH, which is oxidized by the AS(O)-oxidized protein. A 
higher EPR intensity is seen when the protein is treated with AS(O). The EPR spectra show 
samples measured after 2 minutes of CPH reaction with protein. The bar graph represents an 





sulfhydryl groups detected through Ellman’s assay after treatment of the proteins with AS(O) 
or AS(R). e, HLPT activity calculated from electrochemical measurements after incubation 
with AS(O) or AS(R). Inset shows the reaction of HCY as it is oxidized at the electrode. 
Measurements in c were done in duplicate. Measurements in d and e were done in triplicate.  
All error bars indicate s.d. Two-tailed, unequal variance student t-tests were run on c,d,e. * 
indicates  p<0.05, ** p<0.01, *** p<.001, ****p<0.0001.  AS(R) and AS(O) are reduced or 
oxidized acetosyringone, respectively. CPH is the electron paramagnetic resonance (EPR) 
spin probe 1-Hydroxy-3-carboxy-2,2,5,5-tetramethylpyrrolidine – HCl. HLPT is fusion 
protein. LuxS and Pfs are the catalytic enzymes within HLPT.  
 
To test if AS(O)’s oxidation of HLPT affected activity, 1.5 µM HLPT was 
treated with AS(O) as above, then incubated with enzyme pathway precursor, S-
adenosyl-homocysteine (SAH) (1 mM, 37 °C). At the end of the incubation (3-3.5 
hours) the amount of Hcy produced was measured and HLPT activity was calculated. 
Our results show that HLPT activity decreased linearly with exposure time and 
proportionally to the AS(O)/HLPT ratio (Fig. 2.6 d and Supplementary Fig. S2.3). 
These demonstrate that HLPT activity is attenuated by AS(O) oxidation - an 
electronically-controlled process.  
 
We next tested our main hypothesis – electric assembly of HLPT on a chip 
and in situ activity attenuation. For these on-chip experiments, the biohybrid device 
(assembled as described in Methods) was immersed in a solution of AS(R), where it 
served as the working electrode. In a one step process, the electrode was biased at 





(Fig. 2.7 b). An amplified current output similar to that of solution-based oxidation 
was observed (Supplementary Fig. S2.4 a). To test our hypothesis that input charge 
correlates with decreased on-chip activity, both end-of-reaction and real-time 
measurements were performed. Enzyme-laden chips were biased at +0.55V for 
different times (10-1000 sec – resulting in different levels of accumulated input 
charge and oxidation of AS), after which they were incubated with the SAH substrate 
as before to allow Hcy and AI-2 generation. We calculated enzyme activity and found 
a linear decrease followed by a plateau at long exposure times (Fig. 2.7 c). Control 
reactions showed that both the oxidizing voltage (+0.55V) and the presence of AS 
were needed for attenuation (Supplementary Fig. S2.4 b). The observed linear 
decrease supports a conclusion that as more AS is oxidized at the surface, it reacts 
with and oxidizes more HLPT on the electrode – reducing its activity proportionally. 
Correspondingly, this was dependent on the amount of active HLPT present- as can 
be seen from the three different series of chips, each with different initial activities. 
Also, Hcy increased nearly linearly over time as indicated by our real time 
measurement. Finally, these measurements correlated with our “end-of-reaction” 






Figure 2.7: On-chip enzyme activity is linear with input charge.  a, Immobilization 
of enzyme onto a silicon chip involves chitosan electrodeposition as a thin film followed by 
enzymatic assembly of HLPT. Fluorescent pictures of red-labeled chitosan and blue-labeled 
HLPT show film and enzyme co-localization onto the gold patterned electrode. b, Schematic 





used to oxidize the AS (grey to brown hexagons) in the vicinity of the protein and leads to 
activity attenuation. Activity is then measured by electrochemical detection of Hcy (green 
hexagon) as described in the text. c, Correlation between the input charge applied for in situ 
AS oxidation as in b and the Hcy measured from HLPT thusly attenuated at the end of 3.5 
hours of incubation. Three series are depicted, with different initial enzymatic activities. 
There are two activity and four input charge measurements per data point. Error bars indicate 
s.d. R2 values indicate Pearson correlation coefficients for linearity for the displayed averaged 
data. Values for Pearson and Spearman rank coefficients for monotonic correlation for all 
non-averaged data are, respectively- 0.81 and -0.91 for activity level 1, 0.92 and -0.93 for 
activity level 2, and 0.92 and -0.96 for series 3. Au is gold, Si is silicon. Hcy is homocysteine. 
mC is milliCoulombs. HLPT is fusion protein.  
We then estimated the apparent numbers of electrons needed to deactivate one 
HLPT molecule for each on-chip reaction (see Supplementary Information for 
calculations and discussion). We found this number (30-90) to be of the same order of 
magnitude as the predicted number of target sulfhydryl residues that could be 
oxidized on the protein complex (based on crystal structures 53,54).   
We then asked whether we could predictably “tune” the activity of an 
assembled enzyme complex to a specific “setpoint”. For these experiments, which are 
outlined and discussed in Supplementary Information, we utilized electronic signals 
to both load more than a sufficient amount of enzyme onto the chip and then “tune” 
the activity by calculating the needed charge and biasing the electrode for the 
estimated duration. In one envisioned application, this method might enable design 






Finally, the principal motivation of our concept was the ability of the 
biohybrid device to translate electrical signals to modulate complex biological 
behavior – including cell phenotype. We sought to demonstrate that on-chip 
modulation of HLPT affected generation of both Hcy and AI-2 and then, that AI-2 
would affect the bacterial phenotype. In our case, this was the generation of a blue 
fluorescent protein among engineered Escherichia coli bacteria (Fig. 2.8 a). We 
prepared HLPT-immobilized electrode chips as before, and applied varied amounts of 
charge to attenuate enzymatic activity to various desired setpoints. As before, we let 
the enzymatic reaction take place, and electrochemically measured the amount of Hcy 
generated. Then, after exposing the cells to the solution containing AI-2, we used 
fluorescence-assisted cell sorting (FACS) to detect the blue fluorescent response. 
Figure 2.8 b shows FACS histogram plots of different fluorescence intensities 
resulting from HLPT-immobilized chips modulated using the indicated amounts of 
charge. Our results confirmed electrically-controlled generation of bacterial 
communication molecules (in the same proportion as Hcy) and similarly modulated 
biological signaling as indicated by cell fluorescence (Fig. 2.8 c) - meaning that we 
could predict and feedforward control biological behavior from our electrochemical 
Hcy measurements. Moreover, this first-ever finding shows that population-wide 






Figure 2.8: In situ enzyme attenuation mediates biological signaling. a, Schematic 
of experiment: HLPT is attenuated in situ as in Figure 2.7. The generated solution with AI-2 
is added to reporter cells, which fluoresce blue. A bright field image of the cells is overlaid 
with the blue fluorescent image, showing co-localization of cells and fluorescence. b, 
Histograms from FACS (measuring blue DAPI fluorescence) run on AI-2 reporter cells to 
which the products of differentially-attenuated HLPT-immobilized electrodes were added. c, 
Comparison of the Hcy measured electrochemically and the average blue fluorescence of AI-
2 reporter cells from HLPT immobilized on an electrode and attenuated with the indicated 
input charges. Cell fluorescence averages correspond to those in the histograms in b. Three 
measurements were taken for the activity in c, and error bars indicate s.d. The Pearson 





averages in c yielded an R2 value of 0.98 (indicated). AI-2 is autoinducer-2. HCY is 
homocysteine. HLPT is the electrically-attenuated fusion enzyme. mC is milliCoulombs.  
 
These combined results suggest that AS(O)-driven on-chip electronic 
attenuation may be a predictable process for our biohybrid device, and support our 
hypothesis that input charge correlates with both enzyme activity and the generation 
of two different biochemical products. Importantly, the assembly methods are 
biologically benign and device operation is enabled without the need for multiple 
liquid samples. This was envisioned for in vitro metabolic or pathway 
engineering29,30. We anticipate that our system and methods can easily be applied in 
microfluidic devices with embedded micro-scale electrodes. Indeed, our group has 
already demonstrated functional enzyme assembly on a chitosan layer, as well as 
electrochemical small-molecule measurement inside of microfluidic channels29,55.  
In the Supporting Information, we show generalized application of our 
method. We characterized chip actuated assembly and attenuation of two additional 
enzymes: (i) a common reporter, β-galactosidase and (ii) a microbial transglutaminase 
used in tissue engineering and other applications56. We found that AS(O) acted 
similarly in oxidizing these proteins and attenuating their activities (Supplementary 
Figures S2.7, S2.8, S2.9). We also used in situ electric oxidation of the alternative 
diffusible redox mediator IrCl63- to show attenuation of HLPT, β-galactosidase and 
microbial transglutaminase, with results similar to those obtained with AS 
(Supplementary Figures S2.7, S2.8, S2.9).  These results demonstrate the wider 






This study provides the first evidence that direct electrical control of a 
diffusible redox mediator, at the surface of a gold electrode in the vicinity of an 
immobilized enzymatic pathway results in predictable protein oxidation, attenuation 
of activity, and biochemical signal generation. We envision that the novel suite of 
methodologies demonstrated here form the basis for targeting and controlling 
biochemical fluxes of other biohybrid devices. We therefore propose this 
methodology as a powerful addition to the biofabrication toolbox57 that furthers the 
utilization of biologically inspired nano-scale processes by bridging the 
communications and fabrication gaps that exist between microelectronics and 
biological systems.  
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Supplementary Figure S2.1: Ir(IV) attenuation of HLPT, Pfs, and LuxS. a, 
Spectrum of  Ir(IV) reacting with HLPT. b, Activity as measured electrochemically of 
samples taken from a over the course of an hour. c, LuxS activity remaining after treatment 
with the indicated mediators. d, Pfs activity after treatment similar to LuxS in c. Activity for c 
and d was measured using Ellman’s assay and electrochemically (which was used to calculate 
the enzyme activity shown). Three samples were measured and averaged for each bar. Error 
bars represent s.d. Ir(III) and Ir(IV) are the reduced and oxidized forms of the redox mediator 






The absorbance falls more than 50 % in the first 5 minutes of the reaction and 
continues to decline steadily until it reaches values similar to those of Ir(III) 
(Supplementary Fig. S2.1 a, Figure 2.4 c). HLPT activity is completely reduced when 
1.5 µM of HLPT is treated with 200 µM of Ir(IV) for one hour, and incubation of 
different HLPT to Ir(IV) ratios results in a predictable trend of activity decrease (Fig 
2.5). Interestingly, the amount of fall in absorbance of Ir(IV) does not directly 
correlate with the same fall in activity, hinting that Ir(IV) may also oxidize residues 
on the protein that are not related to its activity (Supplementary Fig. S2.1 b).  
Incubation of the enzymatic constituents of HLPT – LuxS and Pfs – separately 
with Ir(IV) for an hour also shows a significant decrease in activity, similarly to that 
of HLPT. 1.5 µM LuxS was incubated with SRH and 1.5 µM Pfs with both 1 mM 
SAH and then an active 4 µM LuxS for 3.5 hours. Interesting to note is the negligible 
effect on activity of Pfs from a hydrogen peroxide treatment – known to oxidize 
sulfhydryl groups on proteins58. This may be due to a lack of an SH group in the 
known reaction center of Pfs, as opposed to its presence in LuxS.  
We wanted to investigate whether electrically-oxidized AS or Ir(IV) could 
oxidize HLPT residues, and the nature of that oxidation. AS(O), AS(R), Ir(IV) or 
Ir(III) were added to HLPT, after which the oxidation status of the protein was 
measured. As stated in the main sections, to detect general oxidation we employed 
EPR probe, CPH. When CPH is oxidized (by an oxidized HLPT, for example) its 
radical is revealed and detected. We measured a 5.5 fold increase in CPH radical from 
solutions where HLPT was treated with Ir(IV) (Supplementary Fig. S2.2 a), pointing 






Supplementary Figure S2.2: Characterization of HLPT oxidation by Ir(IV) and 
AS. a, The bar graph of the average of several normalized measurements of EPR intensity of 
HLPT treated with Ir(IV). b,  ICP EOS results  before and after treatment of HLPT with 
either Ir(IV) or AS(O). Both Zn and Fe were recorded. One sample, with error bars indicating 
the s.d of three reads in b. CPH is the spin probe 1-Hydroxy-3-carboxy-2,2,5,5-
tetramethylpyrrolidine – HCl. Ir(IV) is the oxidized form of the redox mediator IrCl6. HLPT 
is the fusion protein under study. AS(O) is the oxidized form of the redox mediator 
acetosyringone. 
 
We then explored whether AS(O) and Ir(IV) would oxidize amino acid residues 
or the divalent cation present in the active site. The cation, a Zn2+ or Fe2+ (depending 
on preparation methods) is necessary for LuxS function and has been said to leach out 
of the protein upon oxidation59. Since sulfhydryl residues can be easily oxidized by a 
variety of oxidants60, and there are several present in HLPT, it was logical to test for 





Pfs, and HLPT after treatment with AS(O) (Fig. 2.6 d).  ICP-EOS determined there 
was no Zn loss from the LuxS active site (Supplementary Fig. S2.2 b). It also showed 
negligible quantities of iron (Fe). Thus, we were able to conclude that AS(O) 
oxidized sulfhydryl residues on Luxs, Pfs, and HLPT, as well as other likely targets, 
but did not seem to affect the presence of the divalent cation in the active site. 
Therefore, HLPT activity decrease due to oxidation by AS(O) may be due to amino 
acid residue oxidation and possible loss of active protein configuration rather than 
oxidation of the active-site Zn. This opens the doors for using AS(O) to potentially 
oxidize and attenuate the activities of other various enzymes, including those with 
sulfhydryl groups vulnerable to oxidation.  
 
Supplementary Figure S2.3: Solution-based AS attenuation of HLPT activity.  
AS(R) or AS(O) at the indicated concentration was reacted with 1.5 µM HLPT for different 
amounts of time. 250µM AS(R) and AS(O) were reacted for 1 hour. Activity decrease shows 
a time-dependent response in the case of AS(O). Three samples were measured and averaged. 
Error bars represent s.d. P values were calculated using student’s t-test (two tailed, unequal 





0.001, **** p < 0.0001. AS(R) and AS(O) are the reduced and oxidized form of the redox 
mediator acetosyringone. HLPT is the fusion protein under study. HCY is homocysteine. 
 
Supplementary Figure S2.4:  In situ attenuation negative controls. a, Observed 
current of oxidizing (+0.55 V) or non-oxidizing (+0.22 V) voltages are applied to 250 µM AS 
and PB solutions with on-chip HLPT. b, Input charges and enzyme activity (homocysteine as 
measured electrochemically) after either 10 or 100 second treatments with the indicated 
mediator/voltage combinations. Three replicates were measured and error bars indicate s.d. 
AS indicates the redox mediator acetosyringone starting out in the reduced form. PB stands 







Supplementary Figure S2.5: Real-time activity measurement. a, In situ monitoring 
of Hcy evolution by HLPT immobilized and differentially-attenuated on-chip. Concentrations 
on the right side correspond to final measurements after 2 hours. b, Correlation between 
slopes of lines in a and final concentrations. R2 value indicates the Pearson correlation 
coefficient for linearity in both a and b. HCY is homocysteine. 
 
“Setpoint” Calculations and Procedure 
The goal of these experiments was to test whether we could predictably “tune” 
the activity of an assembled enzyme complex to a specific “setpoint”. These 
experiments would demonstrate that if we know the initial activity of the assembled 
biohybrid device, we may be able to calculate the charge that needs to be applied in 
order to reach a desired lower activity. In practical applications of our method, this 
would be the way to use feedback control for setting flux through the pathway and 
tuning the enzyme activity in real time. 
First we used electronic signals to load a sufficient amount of the enzyme onto 





to a series of chips, all of which would have the same initial activity. This initial 
activity (tested by reacting only ONE set of chips in the series for 3 hours with SAH 
and measuring Hcy generation) (Step 1 in Supplementary Fig. S2.6) was then placed 
at point (0,y) with y being the calculated enzymatic activity. This point (0,y), was 
placed on the graph in Figure 2.7. 
Our next step was to calculate the exposure line (similar to the trendlines in 
Fig. 2.7 c), which would allow us to predict the needed input charge to achieve a 
decrease in activity. We assumed that the slope of this line would be the average of 
the slopes of the two lines and that it would fall between on Fig. 2.7 c. The slope of 
our new line along with the point (0,y) allowed us to calculate the x-intercept and 
place the line on the graph (the equation of the line is given in Supplementary Fig. 
S2.6). We then decided on the decreased activity that we wanted to tune down to – in 
our example it was 0.15 nmol Hcy/(min*cm2) (Step 2 in Supplementary Fig. S2.6).  
We used the equation of this line to determine the needed exposure 
charge/time (-2.25 mC, about 81 sec) at +0.55 V to hit our desired activity level. We 
then biased several of the chips from the series at or near the calculated time (Step 3 
in Supplementary Fig. S2.6). These additional chips were used for application of +/- 
1mC of charge so that we could have additional values to test linearity and 
robustness. All attenuated chips were then incubated with SAH as before and their 
activity measured. Presumably, if the chips behaved as predicted, then their activities 
would fall on the line.  Specifically, we expected the activity of the chips biased with 
-2.25mC to be 0.15 nmol Hcy/(min*cm2). The error bars on both axes of the line in 





the two adjacent lines on Fig. 2.7 c (the same lines as those used for the average slope 
calculation). 
In Supplementary Figure S2.6 we can see that our results (red dot) after 
attenuation with the calculated charge are within the error range of the predicted 
values (lighter red dotted circle).  The additional electrode chips (yellow dots) also 
followed the predicted trajectory. Overall, we conclude that electronic attenuation of 
HLPT using AS is predictable and a desired activity can be reached by performing the 
calculations above. 
 
Supplementary Figure S2.6: Predictability of input charge and homocysteine 
generation. Three replicates were measured and error bars show s.d. The equation of the 
line was generated as described in the discussion. HCY is homocysteine. 
 
Estimation of Electrons Used to Attenuate a Single Protein Molecule On-Chip 
Our hypothesis is that the amount of input charge correlates to activity 





specifically predictable amount of protein residues. These numbers were estimated 
for electrode-immobilized proteins.  
First, the average specific activity in nmol HCY/(min*mg) was calculated 
from electrochemical measurements of known concentrations (and therefore amounts 
in mg) of the protein (1.5,2,4,8 µM). This average activity was then used to determine 
approximate amounts of protein that were immobilized on an electrode - assuming 
activity was similar to the average calculated for the solution-based protein.  
The mg of protein present that were active on the chip were then converted to 
moles of protein based on molar mass (approximately 50 kDa), and finally to 
molecules of the protein. We thus had the number of active protein molecules on each 
attenuated and non-attenuated electrode. Again, this was calculated from the amount 
of Hcy generated from the chips. 
To calculate the number of electrons that each molecule of protein was 
attenuated by, we first calculated the number of electrons that were used for each 
input current by dividing the total input charge by the charge of an electron. Then, we 
subtracted the molecules of protein for a specific sample from that of the positive 
control (which was not attenuated) to find the apparent decrease in the number of 
active protein molecules due to the input of current.  
The number of electrons used to attenuate a particular sample was then 
divided by this decrease in number of active protein molecules. This yielded the 
average number of electrons that were needed in order to attenuate one molecule of 
protein for a particular data point. This number (30-90) was on the same order of 





include primarily cysteine, but also methionine, lysine, arginine, proline, threonine, 
histidine, and tyrosine, which can be oxidized by a variety of oxidants, though of 
course not all of these residues would be accessible 61.  Additionally, electrons were 
probably used to alter the pH, the chitosan scaffold, and other environmental 
conditions. We believe that these numbers show that we do indeed have a quantifiable 
and predictable number of electrons that are used to attenuate each protein molecule. 
Furthermore, such a number would differ for different proteins and mediator 
combination and could be useful for determining the amount of current needed to 
attenuate a specific protein down to a desired activity level.  
 
Electronic Attenuation with Additional Mediators and Proteins 
The circular electrode chip described in Methods was used for all on-chip 
attenuation experiments in this section.  
 
Attenuation of HLPT with the Mediator Ir on a Chip 
HLPT was assembled on a chip using the same methods as previously 
described. Ir(III) was used as the mediator, at a concentration of 500 µM in phosphate 
buffer pH 7. A method identical to the one described in the methods section for on-
chip attenuation was used to oxidize Ir(III) to Ir(IV) in situ, which would then oxidize 
the assembled HLPT and attenuate its activity. Above, we show that Ir(IV) is able to 
oxidize HLPT in a time and concentration-dependent manner in solution. Here we 
wanted to illustrate that on-chip attenuation of HLPT can also be done with in situ 





the Methods section, and activity was measured and calculated again in the same way 
as before. The results below in Supplementary Figure S2.7 show that we saw a 
similar trend in activity attenuation by electronically-controlled oxidation of Ir(III) as 
we did with AS(R). When plotted on the same graph as in Figure 2.7 c, the leveling-
off of activity decrease due to input charge is at a similar value to the other series, but 
the slope does seem to differ significantly.  
 
Supplementary Figure S2.7: On-chip attenuation of HLPT with Ir. a, The enzyme 





attenuation of HLPT on-chip with the indicated input charges in a solution of 500 µM Ir(III).  
Three replicates for each data point were measured and error bars show s.d. The R2 value was 
calculated from the Pearson coefficient for linearity. b, The same data as in a, only plotted on 
the same axes/graphs (lightened here) as in Figure 3c to show for comparison. Ir is the 
iridium redox mediator. HCY is homocysteine. 
 
Attenuation of the Enzyme β-galactosidase On-Chip with Both AS and Ir 
β-galactosidase is a commonly-used genetic reporter protein and an enzyme 
that hydrolyzes β -galactosides to monosaccharides. It is a well-studied sulfhydryl-
containing enzyme with 19 cysteine residues per subunit 62. These SH groups are 
believed to be important for maintaining the active conformation of the enzyme. 
We first tested whether Ir(IV) and AS(O) can be used in solution to attenuate 
its activity. β -galactosidase was first diluted in 40 mM Tris HCl pH 7.5 to a 
concentration of 0.2 U/µl. Then, 5 µl (for Ir) or 1 µl of a 0.04 U/ µl stock (for AS) of 
this enzyme was incubated in 100 µl total with the indicated concentrations of Ir(III), 
Ir(IV), AS(R), and AS(O) in 40 mM Tris for 30 minutes (for Ir) or 2 hours (for AS). 
To measure the remaining activity, 10 µl of o-nitrophenyl β-D-galactopyranoside 
(ONPG) at 4 mg/ml was added. Another 30 minutes (for Ir) or 2 hours (for AS) were 
given for the reaction to take place at room temperature, during which the ONPG 
substrate is hydrolyzed by the enzyme to form o-nitrophenol (which is yellow) and 
galactose. The yellow product can be detected at 420 nm in a clear-bottomed 96-well 
plate in a standard plate reader. The results below in Supplementary Figure S2.8 
indicate that Ir(IV) and AS(O) were able to attenuate β-galactosidase activity, 






Supplementary Figure S2.8: Attenuation of β-galactosidase activity. a, Enzyme 
activity as indicated by the OD 420 measurement of the substrate evolution after treatment 
with either reduced (III) or oxidized (IV) Ir as indicated in the method. b,  Enzyme activity as 
indicated by the OD420 measurement of the substrate evolution after treatment with either 
AS(R) at 1000 µM or the indicated concentration of AS(O). c, On-chip attenuation of β-
galactosidase with either 500 µM Ir or 500 µM  AS, as described in the method in this 
section. Enzyme activity is measured by the OD 420 of the substrate evolved. Error bars 
indicate s.d from three measurements for a and b, and three for the Ir series in c and four for 





linearity for the linear portion indicated by the trendlines in c. For a and b two-tailed, unequal 
variance student’s t-tests were performed for comparing against the 0 - concentration - treated 
positive control. ** indicates p < 0.01, *** p<0.001, and **** p < 0.0001. Ir(III) is the 
reduced form of the redox mediator IrCl6, and Ir(IV) is the oxidized form. AS(R) and AS(O) 
are the reduced and oxidized forms of the redox mediator acetosyringone. 
 
In order to apply our on-chip attenuation method for β-galactosidase we had to 
modify the steps required for assembling the protein onto the chitosan surface. Since 
we purchased the enzyme and it did not contain an engineered tyrosine tag for us to 
use for tyrosinase-mediated assembly, we used an alternative method developed by 
our group for use with such proteins. This method involves the mixing of the protein 
and the chitosan and the co-deposition of the protein within the chitosan film. It has 
been successfully applied to several enzymes 63-65. Here we were able to successfully 
use this for β-galactosidase deposition, and retained activity of the enzyme within the 
chitosan scaffold on the electrode chips. We diluted the enzyme to 1 U/µl in 0.8% 
chitosan and co-deposited for 2 minutes at 4 A/m2, after which the chip with the 
chitosan/enzyme film was gently washed and stored in 40 mM Tris HCl pH 7.5.  
For on-chip attenuation, we again used the procedure outlined in the Methods 
and used either 250 µM AS(R) or 500µM Ir(III) in phosphate buffer, and biased the 
chips for various times and with a variety of input charges. After attenuation, each 
chip was incubated with 100 µl of 0.4 mg/ml ONPG at room temperature for 2 hours. 
These samples were collected and read in a plate reader at 420nm. We can see from 





and AS in situ, and the activity attenuation seems to correlate with the amount of 
charge that was used. 
 
Attenuation of Microbial Transglutaminase with Ir and As 
Microbial transglutaminase (mTG) is another commonly-used enzyme, and 
catalyzes the formation of a covalent bond between a free amine group (e.g., protein- 
or peptide-bound lysine) and the acyl group at the end of the side chain of protein- 
or peptide-bound glutamine.  
To measure mTG activity, a reaction solution of 31 mM CBZ-Gln-Gly, 174 
mM Tris pH 6, 87 mM hydroxylamine, 8.7 mM glutathione (reduced form) and 4mM 
calcium chloride was made. This reaction solution would then be added to the mTG 
in the indicated volume and incubated at 37 °C. Then a stop solution consisting of 5 
% w/v FeCl3 and 12 % v/v Trichloroacetic acid in deionized water was added at the 
indicated volume. This results in a brown color change, which can be measured at 
525 nm in a plate reader. For measuring on-chip activity, the Tris pH was at 7 to 
prevent the dissolution of the chitosan membrane. 
We first tested mTG for activity attenuation by exposure to Ir(IV) and AS(O) 
as with β-galactosidase above. mTG was from Ajinomoto (Chicago, IL), and was 
used at a stock concentration of 30 U/mg. To test attenuation of mTG in solution, Ir 
(III), Ir(IV), AS(R), and AS(O) at 1 mM stock concentrations in PBS were used. 1 µl 
of the mTG enzyme (at about 5 mg/ml) was incubated with the indicated 
concentrations in a total of 10 µl in PBS for 2 hours. For attenuation testing with 





37 °C incubation for 30 minutes. 50 µl of the stop solution was then added to the 
reaction, after which the OD at 525 nm was read on a plate reader. For Ir(III) and 
Ir(IV) attenuation, 1 µl was incubated with the indicated concentrations  in a total of 
10 µl in PBS for 30 minutes, after which the samples were washed with PBS as 
HLPT was previously, to dilute out the Ir. The same volumes of the reaction and stop 
solutions were added. The results below in Supplementary Figure S2.9 show that as 
with HLPT and β-galactosidase, mTG was attenuated with Ir(IV) and AS(O) but not 







Supplementary Figure S2.9: Attenuation of mTG activity. a, Enzyme activity as 
indicated by the OD 525 measurement of the substrate reaction with the stop solution after 
treatment with either AS(R) at 900 µM or the indicated concentration of AS(O) as indicated 
in the method. b,  Enzyme activity as indicated by the OD 525 measurement of the substrate 
reaction with the stop solution after treatment with either Ir(III) at 900 µM or the indicated 





mTG with either Ir(III) or Ir(IV), or untreated. d, On-chip attenuation of mTG with either 500 
µM Ir or 250 µM AS, as described in the method in this section. Enzyme activity as in a and 
b. Error bars indicate s.d from three measurements for a, b, and c, and two to three for both 
series in c. The R2 values were calculated from the Pearson correlation coefficient for 
linearity for the linear portion indicated by the trendlines. For a and b two-tailed, unequal 
variance student’s t-tests were performed for comparing against the untreated positive 
control. * indicates p < 0.05, ** p < 0.01, and *** p<0.001. Ir(III) is the reduced form of the 
redox mediator IrCl6, and Ir(IV) is the oxidized form. AS(R) and AS(O) are the reduced and 
oxidized forms of the redox mediator acetosyringone. 
 
For on-chip attenuation, we again used the procedure outlined above for β-
galactosidase to entrap mTG within the chitosan. A 3 U/mg mTG in 0.8% chitosan 
solution was used, after which the chips were stored in PBS. For in situ attenuation, 
250 µM AS(R) or 500 µM Ir(III) in phosphate buffer were used, and the chips were 
again attenuated for various times and with a variety of input charges in the same 
manner as before. Each chip was then incubated with 75 µl of the reaction cocktail as 
above at pH 7, at 37 °C for 3 hours. These samples were collected, 50 µl of stop 
solution was added, and read in a plate reader at 525 nm. We can see from the figure 
above that we were able to attenuate mTG activity with both Ir and AS in situ, and the 
activity attenuation seems to correlate with the amount of charge that was used, as in 
our results in Figure 2.7, as well as above in Supplementary Figures S2.7 and S2.8. 
We believe that the results in the above figures demonstrate that our method 
can be expanded beyond our model protein HLPT and the mediator acetosyringone. 





applied – and this might need to be determined on a case-by-case basis. We did not 
optimize the concentrations of the mediators nor the times of exposure or reaction in 
this section, but we do believe that further optimization could show more interesting 
trends. On the other hand, without optimization we found consistent results, 
demonstrating robustness. Additionally, perhaps proteins that are resistant to 
oxidation would be harder to oxidize using this method.  





Chapter 3: Electrochemical measurement of the β-galactosidase 
reporter from live cells: a comparison to the Miller Assay 
 
The majority of this section is adapted from a manuscript currently in review at ACS 
Synthetic Biology with the same title as the chapter. 
Chapter abstract 
With our ever-expanding abilities to construct complex synthetic biology 
systems, facile, real-time monitoring techniques to assess the performance and 
dynamics of these systems must be concomitantly developed and understood. 
Electrochemical monitoring offers the above advantages largely because signal 
transduction stems from direct electron transfer – allowing for potentially quicker and 
more integrated measurements. One of the most common genetic reporters, β-
galactosidase, can be measured both spectrophotometrically (Miller assay) and 
electrochemically. However, since the relationship between the two is not well 
understood, the electrochemical method has not yet garnered the attention of 
biologists. With the aim of demonstrating the utility of the method to the synthetic 
biology community, we created a genetic construct that interprets and reports (with β-
galactosidase) on the concentration of the bacterial quorum sensing molecule 
autoinducer-2. In this work, we provide for the first time a correlation between 
electrochemical measurements and Miller Units – enabling the meaningful 
interpretation of electrochemical signals by synthetic biologists. We show that the 





prediction of one from the other, and for continuous monitoring of cell response. We 
further present a conceptually simple and generalized mathematical model for cell-
based β-galactosidase reporter systems that could aid in building and predicting a 
variety of synthetic biology constructs. This first-ever in-depth comparison and 
analysis aims to shed light on and facilitate the use of electrochemical real-time 
monitoring in the synthetic biology field as well as open doors towards creating 
constructs that can more easily communicate information to electronic systems. 
 
Introduction 
Synthetic biology motivates the rewiring of biological systems for a myriad of 
applications, including sensing, directed feedback response to various inputs and the 
production of valuable products 66. One of the aims of the field is to uncover the 
underlying design principles of biological systems through the rational design of gene 
and protein circuits67,68. Engineered biological systems have already contributed 
significantly to our understanding of how natural systems function and interact 69-71. 
Complex genetic circuits and feedback loops have given us quantitative 
understanding of gene expression and signal transduction 72,73, insights into the 
diversity of behaviors that result from various control loops 74, and the ability to 
rationally control spatial organization and interactions between cells 75-77. 
For ease of analysis and for developing designs, genetically engineered cells 
generally use a set of well-characterized reporters, typically fluorescent proteins such 
as green fluorescent protein (GFP) or enzymes such as β-galactosidase (β-gal)78. 





tracking of protein expression in live cells over time under varying conditions with 
intracellular resolution. In contrast, enzymatic reporters offer high sensitivity through 
signal amplification. Because the enzyme continually generates more detectable 
product over time, very small amounts of the enzyme can be measured. Requiring 
lower copy numbers of reporter in order to achieve a desired sensitivity eases the 
transcriptional/translational burden on the cell79 so that the process of detection does 
not independently influence the system’s biology. 
The β-gal reporter enzyme is one of the most common genetic reporters, and 
its standard analysis using the Miller assay80 is a textbook example of a well-
quantified method for measuring protein expression and enzyme activity. Typically, 
cell samples are collected and lysed at specified time points, and the freed enzyme is 
allowed to react with the substrate, ortho-nitrophenyl- β –galactoside (ONPG). The 
yellow-colored product o-nitrophenyl (ONP) is produced by enzymatic cleavage and 
is quantified by measuring absorbance. The amount of product, the extent of the 
enzymatic reaction and the amount of cells in the sample are used to calculate Miller 
Units, which can be used to compare gene expression across samples taken under 
various conditions. Although reliable, the Miller assay has critical limitations.  The 
assay requires cell lysis, which prevents continuous measurement or localization of 
the signal within a cell population.  Diffusion and reaction of a different β-gal 
substrate, X-gal, provides an optical measure of LacZ localization but makes 
quantification more difficult. These constraints become more problematic as 
researchers move from traditional flask and well-plate formats towards microfluidic 





measurements. As a result, recent influential papers in synthetic biology have mainly 
relied on fluorescent reporters13,81,82. 
Since one of the aims of synthetic biology is to progress towards analysis and 
control over natural circuits as well as the design and manipulation of synthetic parts, 
we must have measurement techniques that track closely with the dynamics of the 
synthetic system. Such techniques would further the construction of more predictive 
models of metabolic and cellular networks for both understanding existing and 
engineering novel circuits. This paper is largely motivated by the great work of the 
biosensor and biochip community, where researchers have used the redox molecule p-
aminophenyl β-D-galactopyranoside (PAPG) as a substrate for electrochemically 
measuring β–gal activity both inside and outside of cells83-91. Many of these systems 
focus on the development of sensitive electrode and biochip systems that can provide 
real-time measurements on the microscale, are cost-efficient, and allow easy 
integration with electronic systems.   
Electrochemical sensing uses electron exchanges between redox-active 
molecules and electrodes to generate measurable electrochemical signals. The fast 
kinetics of electrochemical methods make them promising for dynamically 
monitoring constructs of synthetic biology.  Additionally, the electronic output 
provides quantitative data that can be easily analyzed and used in modeling the 
system.  However, many such electrochemical devices for β-gal measurement are 
manufactured in-house, precluding their proliferation among synthetic biology 
laboratories. Moreover, there remains no direct comparison to a standard that is well 





investigate the relationship between the electrochemical (using PAPG) and 
spectrophotometric (using ONPG) methods of measurement of β–gal to better help 
those familiar with the Miller Unit understand how to take advantage of 
electrochemical sensing.  
Here, we show for the first time that the electrochemical substrate PAPG can 
be used to detect β–gal in a manner comparable to when ONPG is used as a 
spectrophotometric substrate. We demonstrate the electrochemical method by 
quantifying the responses of both whole cells expressing β–gal and lysed cells, and 
correlate both responses to the Miller assay. We created a whole-cell biosensor that 
detects the quorum-sensing molecule autoinducer-2 (AI-2) and responds by 
producing β–gal in a concentration-dependent manner. The genetic circuitry is 
generalizable to any stimuli or molecular cue that evokes a cell response, contingent 
on a genetic link to a natural or synthetic promoter. We specifically chose to detect 
AI-2 because it is a molecule secreted by over 55 bacterial species and facilitates 
quorum sensing (QS)92. QS represents population dependent bacterial communication 
and response and mediates bacterial virulence and biofilm formation93. QS is 
particularly relevant as the problem of antibiotic resistance escalates94. Thus, in our 
example, we utilize synthetic biology constructs to transduce molecular signals that 
mediate biomolecular cell-to-cell communication into electrical output signals that 
can be further quantified, analyzed, and modeled. 
We use both our electrochemical and spectrophotometric data to create a 
computational model of the biosensor under both lysed and whole cell conditions, and 





the Miller assay. With this framework, researchers can measure whole cell response 
with all the advantages of electrochemical detection, without sacrificing 
understanding of the underlying genetic response. Overall, our in-depth analysis of 
the whole-cell electrochemical AI-2 biosensor and corresponding computational 
model furthers the use of electrochemical monitoring for synthetic biology.  
 
Materials and Methods 
Chemical Reagents and Biocomponents  
4-aminophenyl β-D-galactopyranoside (PAPG), 4-aminophenol (PAP), β-
galactosidase (β-gal) and ortho-Nitrophenyl-β-galactoside (ONPG) were from Sigma-
Aldrich. PAPG was dissolved in diH2O and β-gal was dissolved in 40 mM Tris-HCl. 
PAP and ONPG were dissolved in 0.1 M phosphate buffer (PB). “In vitro” 
autoinducer-2 (AI-2) was produced through previously described biological 
nanofactories95. Briefly, the nanofactory fusion protein HGLPT (His6-protein G-
LuxS-Pfs-Tyr5) was purified from E. coli BL21 luxS- and incubated with 1 mM of the 
substrate S-(f’-deoxyadenosin-5’)-L-homocysteine (SAH) at 37° C with shaking at 
250 rpm, resulting in AI-2 synthesis. The enzymatic reaction product was twice 
extracted by an equal volume of chloroform. 
 
Electrochemical PAP Detection 
 PAP was detected electrochemically through cyclic voltammetry (CV). CVs 





instruments, Inc.) using an Au working electrode (2 mm diameter, CH Instruments, 
Inc.), a 4 cm-long platinum counter electrode (Alfa Aesar), and Ag/AgCl reference 
electrode (BASi). CVs were run from -0.15 to 0.3 V at a scan rate of 50 mV/s. The 
current at the reduction peak was used to measure PAP concentration. 
 
Bacterial Strains, Plasmids and Culture Conditions 
 In order to enhance the AI-2 responsiveness of E. coli ZK12696, a double 
chromosomal knockout of lsrFG and luxS strain, CT108, was created using one-step 
inactivation method97. Briefly, pKD4 was PCR amplified using primers lsrFGHP1, 
ATGGCAGATTTAGACGATATTAAAGATGGTAAAGATTTTCGTGTAGGCTG
GAGCTGCTTC, and lsrHP298. The PCR product was electrically transformed into 
ZK126 pKD46 (to express the Red recombinase). lsrFG:Kanr recombinants were 
screened with kanamycin and pKD46 plasmid was cured by growing at 37oC.   After 
confirming the gene replacement by PCR, the kanamycin resistant gene, Kanr, was 
removed by transforming a helper plasmid, pFLPe-Tet (Gene Bridges), to express the 
FLP recombinase. Then luxS was knocked-out from ZK126 ΔlsrFG following the 
similar procedure published before98. CT108 was created after the removal of the 
kanamycin resistance gene similarly descripted as above. Plasmids pCT699 and then 
the commercially-available pET200/D/LacZ (Life Technologies) were introduced via 








Miller Assay (Colorimetric β-gal Activity Detection) 
 Miller assay was performed according to standard protocols80. Briefly, cells 
were lysed with chloroform and sodium dodecyl sulfate (SDS) to release β-gal. The 
substrate ONPG was added and cleaved by β-gal into a yellow molecule, o-
nitrophenol. Absorbance at 600 nm, 550nm, and 420 nm was quantified by a 
Molecular Systems plate reader.  The OD at 600nm was measured from 250 µl of 
cells and the ODs at 420 nm and 550 nm were measured from 200 µl of cells.  
 
AI-2 Detection with Bacterial Biosensor 
 E. coli CT108 pCT6/pETLacZ was grown in LB Broth, Miller (Fischer 
Scientific) at 37°C with aeration by shaking at 250 rpm, then reinoculated at 2% and 
grown to early log phase (OD600 0.2). Cells were incubated with AI-2 at 37 °C with 
shaking at 250 rpm, then spun down and resuspended in phosphate-buffered saline 
(PBS) at an OD600 of 2. 0.5 mg/mL PAPG was added and CVs were performed as 
described above. To validate the electrochemical results, the commonly used Miller 
assay was performed on lysed cells to quantify β-galactosidase activity. 
 
Cell Lysis 
 10 % chloroform and 0.005 % SDS were added to cells resuspended in PBS. 
The reaction was vortexed and incubated at room temperature for 5 min. For 
absorbance measurements, the reaction was spun down for 4 minutes at 8000 rpm and 





the reaction was spun down for 1 minute at 14,000 rpm and the supernatant was 
removed for measurement. 
Results and Discussion 
Electrochemical characterization of LacZ expression 
A generalized scheme of the electrochemical detection of PAP to characterize 
cellular LacZ expression is presented in Figure 3.1 a.  Molecular cues signal 
intracellular synthetic biology controllers (represented in abstract form) to drive LacZ 
gene expression, which produces the β-gal enzyme as a surrogate for phenotypic 
output. To perform electrochemical enzyme activity measurements, PAPG is added, 
enters the cell, and is cleaved by β-gal into PAP (Figure 3.1 b), in an analogous 
manner as ONPG is cleaved into ONP for optical measurements. PAP can then exit 
the cell and be detected electrochemically by oxidation to p-iminoquinone using a 
three electrode system (Figure 3.1 b and c)64. The current readout, as can be seen in 
Figures 3.1 d (cyclic voltammetry scan) and e (peak current of the cyclic 
voltammograms), is linearly proportional to PAP concentration over a fairly wide 
range. See Supplementary Figure S3.4 for additional information on the oxidation vs. 
reduction current of PAP. This method allows the characterization of the amount of β-
gal, whether in lysed cells or within an intact cellular environment. Since we foresee 
this measurement method being especially useful in miniaturized lab-on-a-chip 
systems, it is important to note that the sensitivity of smaller electrodes towards PAP 
should not decrease because sensitivity is measured as current/electrode area. 
Additionally, microelectrode edge effects resulting in enhanced diffusion of PAP to 






Figure 3.1: Overall goal schematic and PAP electrochemical characterization. a, 
A general electrochemical biosensing scheme for a cell producing β-galactosidase as a 
reporter (phenotypic output) from a promoter of choice or a combination of genetic elements 
(synthetic biology controller) in response to various molecular cues (AI-2 in this paper). Once 
β-galactosidase is produced, 4-aminophenyl β-D-galactopyranoside (PAPG) is added. PAPG 
enters the cell and is cleaved by β-gal into the redox active molecule p-aminophenol (PAP). 
PAP exits the cell and is quantified through cyclic voltammetry at the electrode. b, Molecular 
structures of the cleavage of ONPG to ONP and D-galactose and PAPG to PAP and D-
galactose by β-gal. c, The counter (C), working (W), and reference (R) electrodes used in this 





of different concentrations of PAP using the setup in c. Inset showing reversible PAP 
oxidation to p-iminoquinone at the electrode. R and O indicate reduction and oxidation peaks, 
respectively. e, PAP standard curve shows correlation between PAP concentration and the 
reduction peak current, taken from d. 
 
Characterization of β-gal produced by biosensor cells 
To study the utility of electrochemical β-gal detection in cells, we constructed 
an E. coli sensor cell strain (luxS-, lsrFG-, Δ(argF-lac)169) that relies on native 
import and phosphorylation of AI-2 to de-repress expression of the lsr promoter 
(Figs. 3.2 a,b). Using a two-plasmid system we amplify the native signal strength (lsr 
promoter) by driving expression of T7 RNA polymerase (from pCT6). This, in turn, 
amplifies gene expression from a generic pET vector, engineered to produce β-gal. 
This two-plasmid expression system provides biological amplification that greatly 
increases the sensitivity of the strain to AI-2, as discussed by Tsao et al. (2010). As 
seen in Figure 3.2 c, the cells respond in a predictable, dose-dependent manner; that 
is, the β-gal response as measured by the Miller assay correlates with the 
concentration of added AI-2. These response trends correspond with our previous 
results for systems involving AI-2 uptake by cells99. Because the stoichiometry of the 
reaction using the electrochemical substrate (PAPG) is the same as that using the 
colorimetric Miller substrate (ONPG), we expect a direct correlation between the 
Miller and electrochemical assays. We selected cells at 3 hours post-AI-2 induction 
for further experiments since the responses were robust and the Miller response 






Figure 3.2: AI-2 biosensor characterization. a, The biosensing scheme for a cell 
producing β-gal as a response to added AI-2. b, The synthetic construct, in which the Lsr 
promoter activation induces β-gal production through a two-plasmid system. Plasmid pCT6 
responds to AI-2 by producing T7 polymerase and activating the T7 promoter on pETLacZ, 
which results in β-gal overexpression.  c, A time-course response to different added AI-2 
concentrations of the above construct, CT108 cells with pCT6 and pETLacZ plasmids. 







Real-time electrochemical vs. spectrophotometric measurement of β-gal activity 
To establish the electrochemical measurement using our electrodes, we first 
used purchased β-gal as a reference material. In Figure 3.3, we characterized β-gal 
activity using both spectrophotometric and electrochemical methods, re-suspending 
the enzyme in either the Miller assay’s Z-buffer or 40 mM Tris-HCl, respectively.  
These experiments provided a basis for quantifying enzyme (g/L) relative to its 
activity using both methods and for estimating β-gal concentration within biosensor 
cells.  
The spectrophotometric technique (Fig. 3.3 b) allows measurements that are 
rapid, sensitive, and linear at low β-gal concentrations. However, we can also see that 
it takes less than a minute for the highest β-gal concentration - 0.005 U/µl - to 
generate an amount of ONP that is no longer in the linear range on the 
spectrophotometer (>1 AU).  Higher concentrations would need to be diluted for 
analysis in the linear range. The electrochemical technique, while also sensitive and 
linear, better differentiates between higher concentrations of β-gal (Fig. 3.3 c); after 
20 minutes of reaction, 0.005 U/µl of β-gal yields a signal still in the linear range. In 
both cases, rates of product generation were higher with increasing enzyme 
concentration (as expected), and the two measurements showed a linear correlation 
with each other (Fig. 3.3 d). Also in Fig. 3.3 d, we can see that the rate of PAP 






Figure 3.3: β-galactosidase activity detection. a, Scheme of real-time electrochemical 
and spectrophotometric detection of PAP or ONP produced by β-gal cleavage of PAPG or 
ONPG. b, Spectrophotometric ONP measurement from reactions of various concentrations of 
β-gal with ONPG over time. c, The same β-gal concentrations and conditions as in b, where 
the activity was instead measured by electrochemical detection of PAPG cleavage to PAP. d, 
Correlation between electrochemical measurement rate of PAP detection to 
spectrophotometric measurement rate of ONP detection from data in b and c, as well as the 





indicate linear trendlines except for 0.005 U/µl in b, which indicates a best fit 2nd order 
polynomial trendline. 
 
Electrochemical response of AI-2 biosensor cells 
We then moved on to electrochemically characterizing the response of our 
biosensor cells, in which we used cell samples after a 3 hour AI-2 induction. Since 
the Miller assay requires cell lysis, we first investigated the electrochemical response 
of lysed cells. The schematic in Figure 3.4 a depicts the relationships between all of 
the system components. PAP current was measured at 0, 5, 10, and 15 minutes after 
the addition of PAPG. As can be seen from Figure 3.4 b, the current rose as a function 
of both time and initial AI-2 concentration. The Miller assay was also performed on 
the same cells at the 0 time point, and in Figure 3.4 c, we found a linear correlation 
between the Miller Units and the rate of PAP detection from the same cells.  
This allows us to correlate the electrochemical measurement to the Miller 
Units. To our knowledge this correlation has never been reported for β-gal expressed 
in any cell type. These data provide direct correlation for the two measurements and 
demonstrate, at least for this synthetic biology application with E. coli, that the assays 
are easily employed for typical experimental ranges. Finally, these data can be used to 







Figure 3.4: Lysed cell electrochemical PAP measurement. a, Scheme of detection of 
AI-2 by electrochemical measurement of PAP production by lysed biosensor cells. b, 
Detection of PAP from cells induced with the indicated AI-2 concentrations for 3 hours and 





detection from the samples in b to the Miller units measured from the same samples, 
indicating a linear relationship and low background. Dotted lines indicate linear trendlines. 
 
In Figure 3.5, we continued our studies with whole live cells. PAP current was 
measured at the 0, 1, and 2 hour time points after addition of PAPG. Recall that 
whole cell measurements are not possible via the Miller protocol, which lyses cells. 
In order to perform measurements in live cells, PAPG and PAP diffusion through the 
cell membrane is required, which can be quantified using electrochemical techniques. 
As seen in Figure 3.5 b, the current response correlates with the initial amount of AI-
2 added, as was the case with the lysed cells. Multiple experiments are shown which 
were performed on different days. A more informative representation of our results is 
shown in Figure 3.5 c, where each point represents both the rate of PAP detection at 2 
hours (as in Figure 3.5 b) and the corresponding Miller results of the same cell 
samples. It is important to note that during those two hours following PAPG addition, 
the quantity of β-gal within the cells did not vary significantly. Figure 3.5 c shows 
correlation (R2 = 0.97, with R2 = 0.92 for all points between the Miller Units and the 
electrochemical response up to about 2000 Miller units. The limit tested for the lysed 
cells was also in this range, and although above 2000 Miller units we noted larger 
deviation linearity was still preserved. We also note that the current-generation rate 
was much lower in whole cells than in lysed cells (Fig. 3.4). The current obtained in 
the 40 µM case for the whole cells reached 1.5 µA after 2 hours, but the same output 





barrier to PAPG and/or PAP transport, in addition to unknown factors that affect the 
molecule’s concentrations or reactions.  
 
Figure 3.5: PAP measurement from live cells. a, Scheme of detection of AI-2 by 
electrochemical measurement of PAP production by whole biosensor cells. b, PAP detection 
from whole cells after incubation with the given AI-2 concentrations for 3 hours and then 
PAPG for the indicated time. Averages are from 3-4 replicates on separate days and error 





Miller Units of the same cell samples shows a linear relationship. Dotted lines indicate 
trendlines. 
 
In Figure 3.6 a, we show a comparison between the lysed and whole cell 
electrochemical response rates, dependent on the corresponding Miller Unit 
measurements. This allows a prediction of the current for either lysed or whole cells 
based on Miller assay results. Again, while the whole cell assay was slower, in both 
cases, linearity was demonstrated. The linear relationships from Figures 3.4 c & 3.5 c 
were used to construct a line in Figure 3.6 b (see Methods for further information and 
calculations), which relates the lysed cell assay to the intact cell assay, both measured 
via electrochemical means. It is evident from the graphs that lysed cell measurements 
are more than an order of magnitude faster than whole cell measurements for 
conditions with similar Miller Unit results. Nonetheless, the fact that the detection 
rates are linear at even low levels of β-gal suggests that relatively rapid analysis of 
gene expression is possible using this method, especially if more sensitive electrodes 
are used. Potentially, a normalized unit comparable to the Miller Unit could be 
calculated from the electrochemical measurements (we present our calculations in the 
Supplementary Information and Supplementary Figure S3.8). Additionally, we 
performed similar preliminary experiments using constructs with single plasmids and 
different promoters and were able to confirm similar trends.  
One aspect that is not obvious from the plot is that the amount of background 
signal for whole cells (~0.005 µA/min, Fig. 3.6 b) was similar to that for lysed cells 





factors: physical PAPG degradation to PAP or other uncharacterized cell processes 
resulting in PAPG cleavage, rather than due to reaction by β-gal.  We note, however, 
that experiments without the addition of PAPG resulted in near zero background 
(Supplementary Figure S3.3), indicating that the cells are not producing additional 
electrochemical species that overlap with the signal of PAP.  
 
Figure 3.6: Lysed vs. whole cell response. a, Comparison of the rates of PAP detection 
from whole versus lysed CT108 pCT6/pETLacZ sensor cells based on measured Miller Units 
in response to different AI-2 concentrations. b, The line indicating the 





points on the line indicate calculated whole-cell rates for lysed cells with specific Miller 
Units. Dotted lines indicate trendlines. 
 
The two-compartment mathematical model 
We constructed a simple computational model that generates β-gal levels and 
PAP concentrations in response to PAPG and AI-2 addition to cells with respect to 
time. In order to build this model, compartments (ie. sub-models) were constructed 
separately (Figure 3.7 a). The first compartment modeled cell behavior (LacZ 
expression) in response to AI-2. The second compartment modeled the production of 
PAP via the substrate PAPG and its response to the enzyme, β-gal. The two sub-
models (Figure 3.7 a, 3.7 b) were combined into one final model that was then 
compared to the lysed cell data. Figure 3.7 c shows that there exists a good 
correlation between the model predictions and the PAP measurements (see also 
Supplementary Figures S3.5-3.7). That is, we have divided the model into two 
compartments so that the latter compartment could be an electrochemical “plug in” to 
the first compartment, which in turn, would be constructed for any generic construct 
wherein the first principles reactions could be conceptualized. In our case, the first 






Figure 3.7: Model comparison with experimental results. a, Model results of cell 
production of β-gal depending on AI-2 induction, converted to Miller Units and overlaid with 
experimental data. Insert indicates modeled processes. b, Model results of β-gal conversion 
rate of PAPG to PAP overlaid with experimental results. Inserted scheme indicates modeled 
processes. c, Model results of lysed-cell production of β-gal and PAP production converted to 







In this work, we report the first in-depth comparison of the electrochemical 
method for measuring β-gal activity in both lysed and intact cells to the gold-standard 
Miller assay. Our results indicate that the electrochemical method is a feasible 
alternative that enables added versatility for analysis of synthetic biology constructs, 
especially in applications exploiting lab-on-a-chip devices or real-time measurements. 
We demonstrated this by developing a biosensor bacterium that converts the signaling 
function of quorum sensing molecule AI-2 to electronic signals through a genetic (β-
gal) and chemical (PAPG) transducer system. Our results showed that the electronic 
current measured was proportional to Miller Units from the same samples, and can be 
used to approximate gene expression in a multi-component synthetic circuit. Such 
electrochemical measurements would allow for in situ analyte detection as they 
integrate seamlessly into electronic systems, and could therefore provide for 
programmable measurements of synthetic biology constructs. Additionally, we 
created a two-compartment model that can be used to predict PAP (and thus 
electrochemical) output from our construct, and can be modified to accommodate 
other systems driving LacZ expression. We believe this work connects, for the first 
time, the work of the biosensor community in enzymatic reporter detection, with the 
standard optical measurement techniques biologists use for the same purpose. A 
better link between synthetic biologists and biochip / microelectronics designers 
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Supplementary Figure S3.1: Biosensor cell response over time. Correlation between 
the concentration of AI-2 used to induce the biosensor cells and the Miller Units, based on the 








Supplementary Figure S3.2: Spectrophotometric and electrochemical 
measurement comparisons. a, The linear correlation between the enzyme units calculated 
from absorbance or electrochemical measurements for lysed cells. b, Similar results as in a 
but with electrochemical measurements coming from whole cells.  
 
Calculations: In order to convert absorbance (Abs/min) or electrochemical 
(µA/min) measurements to   β -gal (U/µl), the following equations were used, 
respectively:  x = (y -0.0016)/134 and x = (y + 0.035)/94.8 (x is the U/µl and y the 
measurement in either Abs/min or µA/min). Both equations were calculated from the 
data in Figure 3.3, where for each β-gal amount a calculated rate (Abs/min or 
µA/min) was found using Excel’s LINEST function. For the absorbance data, the 
highest enzyme concentration’s data was omitted as it was not in the linear range.  
 We can see that in Supplementary Figure S3.2 a, the rates correlate in almost 
a 1-to-1 ratio since in both cases the cells are lysed. In Supplementary Figure S3.2 b, 
however, the electrochemical measurements show a much lower apparent enzyme 
amount compared to the absorbance measurements. This is because although the 





electrochemical measurements were done on whole cells. The relationship allows us 
to calculate the underestimation of the electrochemical whole-cell measurement.  
 
Supplementary Figure S3.3: Control experiments. Performed with biosensor cells 
different than ones used in the main paper, but which behaved similarly. PAPG 
concentrations were 0.5 mg/ml and AI-2 was 40 µM. Procedure was similar to that in the 






Supplementary Figure S3.4: PAP measurement. a, Oxidation currents of PAP 
generated by various β-gal concentrations, same as in Figure 3.3 c. b, Oxidation current of 
PAP generated by lysed cells induced with the indicated concentrations of AI-2, same as in 
Figure 3.4 b. c, Oxidation current of PAP generated by whole cells induced with the indicated 
concentrations of AI-2, same as in Figure 3.5 b. 
 
Calculations for line in Figure 3.6 b  
The line was-calculated by equating the x’s of the two equations of the lines  
in 3.4 c and 3.5 c, representative of the Miller Units, and rearranging the combined 





cells (y2). This allowed for direct conversion of lysed-cell rate to whole-cell rate for 
samples with the same Miller Units. The points on the graph indicate lysed-cell points  
[(x,y) being Miller, current] whose Miller Units were taken and plugged into the 
whole-cell equation to calculate what the whole-cell current would be for cells with 
the same Miller Units (x’s). The results were used as the y’s for the points on the 
graphs, with the x’s being the experimentally-measured lysed cell currents.  
 
The Two-Compartment model 
The model for tracking β-gal activity is a two-compartment model. That is, the 
main model is a construction of two sub-models. The first sub-model is a system of 3 
differential equations that model β-gal activity expressed in cells exposed to different 
levels of AI-2. The known parameter values are taken from literature and the rest are 
fitted to the data. The second sub-model uses the two Michaelis-Menten differential 
equations to model PAP production at various concentrations of β-gal. The Michaelis 
constant (Km1) is taken from the literature. The turnover rate (kcat1) is fitted to the 
data. The two sub-models are combined to create a model that predicts PAP 
concentrations at various levels of AI-2 added. To observe the quality of our 
predictions, the model output is compared to data collected from the lysed cells. 
 
The First Compartment  
Data Conversion 
          In order to fit the sub-model, data was converted from Miller units to µM of β-





converted the absorbance at 420nm into µM concentration of ONP. In order to 
convert µM ONP into µM β-gal, we use the following Michaelis-Menten equations: 
 
with known turnover rate kcat1 = 620/s and Michaelis constant Km1 = 120 µM100,101. 
Eo1 denotes the β-gal concentration (µM). Assuming that Km1 << ONPG, the ONP 
differential equation simplifies to: 
 
The slope is estimated by least squares regression, so Eo1 can be solved at each time 
point to extract the β-gal concentration (µM). 
Model Fitting 
 
For this model, we assume a first order reaction for the influx of AI-2 from the 
outside. We have simplified the intracellular dynamics and provide equations 8-10 
(below) which describe the β-gal enzyme concentration, the LsrR repressor 
concentration, and the amount of LsrR bound to DNA102. These equations base β-gal 
expression on the interplay between LsrR bound as a repressor and its freely 





tetramer bound between two distal looped strands of DNA comprising the intergenic 
region of the lsr regulon103. While a significant simplification of the known 
biochemistry, the topology of the expression kinetics agrees well with our 
experimental observations. For example, we do not include the phosphorylation of 
AI-2 by LsrK. We generalize the transcriptions on the pCT6 and pETLacZ into one 
equation that codes for LacZ and LsrR. Hence, we call k2 a generalized rate as it takes 
into account these factors. The law of mass action is used to translate these reactions 
into differential equations. The constraint CR + DNA = Dtotal, in which Dtotal is a 
constant, simplifies the system of differential equations into: 
 






The application of this constraint is explained in Alon104. However, in our 
equations we did not apply the assumption that 𝑑𝑑𝐶𝐶𝑅𝑅
𝑑𝑑𝑑𝑑
= 0 (steady state amount of 
bound repressor). 
We induced the synthesis of LacZ by the addition of AI-2; typically aiming 
for an initial OD of 0.2. To facilitate errors in dynamic lag associated with altered 
OD’s for induction and to account for variability in initial growth kinetics, we have 
set the initial condition so that the initial appearance of β-gal in the zero AI-2 control 
culture matched with the simulation at that point. This meant that the simulations 
commenced at t =1 .5 hrs, or about a half hour before the initial β-gal measurement. 
The rest of the initial conditions are CR(1.5) = Dtotal – 1.175 × 10-6 µM and R(1.5) = 
1.692 × 10-5 µM. The differential equations were solved using MATLAB. 
Table 2: Parameter values and source 
 
Table 2 shows the parameter values used in the model. Note that for k4 (the 
transcription rate of LsrR and LacZ), we take into account the rate at which the 
endogenous RNA polymerase transcribes the T7RNA polymerase (2.65 kbp at 39 
nt/s)105,106 as well as the rate at which the T7RNA polymerase transcribes LacZ 







Supplementary Figure S3.5. Cell model and data overlay of experimental data. 
 
Converting µM ONP/min data from model to Miller Units for Figure 3.7 a 
In order to convert the data outputted by the model, in µM ONP/min, Miller 
Units were calculated as follows: 
 
To convert the model’s output to an absorbance value at 420 nm (OD420) we 
used Beer’s Law as described above. Since the model data was not actual data from 
cells, we used values for OD550, volume, reaction time, and OD600 that were similar to 
those from the experimental data. 
For the OD550, since the experimental values were all almost identical, we 
used the overall mean for all conversions. The volume and time stayed the same as in 
the experimental data. The OD600, indicative of the amount of cells present, was 





then used to calculate the corresponding Miller Units for the model data and plotted 
along with the experimental data in Figure 3.7 a.  
 
The Second Compartment 
Data Conversion 
First, the data were converted into µM. The data describe concentrations of 
PAP in response to different levels of β-gal. We generated a standard curve that 
converts current (µA) to µM of PAP. Then, we convert to units of β-gal. To convert 
units of purchased and powdered β-gal into µM of β-gal, we introduced a factor of ¼ 
(ie ¼ gram of β-gal for every 1 gram of powdered β-gal). This factor can also 
compensate for the differences between cell-generated β-gal activity and store-bought 
β-gal activity. After fitting the model (explained below), the resulting turnover rate, 
kcat, is closer (103.26/s) to the value stated in literature, (90/s)110.  
 
Model Fitting 
Michaelis-Menten equations were again used for the PAPG substrate and β-
gal enzyme. However, the parameter values (turnover rate kcat and Michaelis constant 
Km) were not documented as well as the ONPG substrate. Viratelle and Yon110 
provided values of kcat = 90/s and Km = 330 µM. Since these values, nor any 
combination of kcat and Km, do not produce a reasonable fit that encompasses all our 
data, we fixed Km and searched for the kcat that minimized the distance between the 
model and the data points.  Overall, the values we found were within expected 





Similar to above in which µM of ONPG was converted into µM of β-gal, we invoked 
a similar assumption that Km << PAPG (excess PAPG). The PAP differential 
equation of Michaelis-Menten then simplified to: 
 
Since we had PAP (µM) at 5 time points for 4 nonzero levels of β-gal, the 
slopes were estimated by resolving a linear fit of each of the four datasets. The slopes 
were applied to the above equation for each level of enzyme to obtain 4 kcat values. 
This provided a range of kcat values that was used to find the best fit kcat by 
calculating the least squares fit of the first four time points (as the fifth time point of 
one of the datasets seemed noisy). The resulting turnover rate was kcat = 103.26/s. 
In this way, we used the average kcat = 103.26/s and the literature value of Km (330 
µM) for our Michaelis-Menten model, shown below. We used this model to describe 
PAP activity after the addition of PAPG to β-gal (Eo). 
 
The model output is shown in Supplementary Figure S3.6 and there is 






Supplementary Figure S3.6. PAP model and overlay of experimental data. 
 
The Combined Model 
The above models (equations 8-10 and 12-13) were then combined into one 
system of differential equations. The output of the combined model was compared to 
the data collected from the lysed cells in which AI-2 was added to the cells and the 
levels of PAP were measured. (Note that cell lysate was used so our results would not 
include any time lag associated with transport of small molecules (AI-2) or proteins 
(β-gal) passing through the membrane.) 
The data collected represents the PAPG that was added to the cell extracts 
after hour 3, with the PAP levels measured in the subsequent 15 minutes, at 5 minute 
intervals. The model was run accordingly and the predictions are shown in Figure 
S3.3 along with the data points. The data support well, the Michaelis-Menten 
assumptions and constants evaluated here and reported by others105-108,111,112. 
Again, there is reasonable agreement between the models and the 
corresponding data, suggesting the mechanisms underpinning the system of ODEs 





claim that because the model simulations and the data match, the mechanistic bases 
are validated. Instead, we suggest that the mechanistic basis for the in vitro 
electrochemical reactions can be faithfully represented by Michaelis-Menten kinetics, 
largely supported by constants obtained by previous researchers, and that the 
simplified cell based model describing the kinetics of β-gal expression is sufficiently 
accurate so that any future cell-based model describing LacZ kinetics could be added 
to sub-model 2 described here. While this is conjecture at this time, it is the primary 
motivation for partitioning the model as described and for including here. 
 
Supplementary Figure S3.7. Final model predictions and lysed cell overlay of 
experimental data. 
 
Determination of a unit for electrochemical measurements analogous to the 
Miller Unit: 
A unit analogous to the Miller Unit would ideally be developed for 
normalizing electrochemical PAP measurements. Below we use our data to 





most similar to the way the spectrophotometric measurements are done to get the 
Miller Units.  
 
In the Miller Unit the OD420 indicates the resulting ONP generated in a volume of 
cells (of OD600) after the indicated reaction time. The OD550 indicates the scatter from 
cell debris, and when multiplied by 1.75 approximates the scatter at 420nm.  
 
Our analogous unit would take into account the current (in µA) measured after the 
indicated time (min) of a specific volume (mL) of cells of a certain OD600.  
In order to further develop and standardize the electrochemically-measured unit, 
measurements would need to be performed with various cell amounts and volumes 
and using different electrode materials, sizes, and setups (the units would likely be 
different based on the electrodes used). Additionally, any background interference 
between the cell lysate and the electrode surface would need to be studied and taken 
into account, especially for smaller electrodes.  Below are our sample calculations for 



















(mL) Cell OD600 
Electrochemical 
Units 
0 0.093 15 1 2 0.003 
5 0.631 15 1 2 0.021 
10 1.220 15 1 2 0.041 
20 2.490 15 1 2 0.083 
40 2.710 15 1 2 0.090 
 
When plotted against the Miller Units from Figure 3.4 c, there is a very good 
correlation (Supplementary Figure S3.8 below), though again, to standardize this unit 
much more data would have to be analyzed.  
 
 
Supplementary Figure S3.8. Normalized Electrochemical Unit vs. Miller Units of 
lysed cells. a, Linear relationship between the Miller Units measure from the lysed 
cells in Figure 3.4 c and the electrochemical units calculated as described above from 







Chapter 4: Electronic control of bacterial gene expression through 
redox-driven transcriptional activation 
 This chapter will be turned into a manuscript after some additional work is 
done and submitted by the end of 2015. 
Chapter abstract 
The engineering of directional, efficient, and programmable communication 
between living and nonliving systems has immense potential to harness the distinctive 
features of each for a variety of applications in both clinical and research settings. 
However, living cells use small molecules, ions, and protein assemblies to send 
signals, while electronics utilizes electrons.  Here we present the novel use of redox 
molecules to shuttle information from electronics to Escherichia coli (E. coli) cells. In 
our original method, electronic control of the state of the redox molecules pyocyanin 
and ferricyanide, to which the cells have been engineered to respond with the use of a 
single promoter, allows for electronic gene control. We show that the signal output 
(cell response) is dependent on the amplitude and frequency of signal input 
(electronic charge), allowing for a tunable response. The biological and metabolic 
underpinnings and effects of the method are also characterized. This work shows for 
the first time the use of redox mediators to control genetic expression in a reversible 
and programmable manner, and furthers technologies that aim to combine living and 






Communication and information transfer between biology and electronics is a 
highly sought-after functionality with many applications in both clinical and research 
settings. If we are to make the best predictions and analyses of diseases as well as 
study and manipulate the biological environment, we need to grant cells the ability to 
interpret electric signals into specific pre-programmed functions, which would allow 
us to manipulate and study cellular behavior with an unprecedented degree of 
precision. Moreover, gaining electronic control of cell functions would advance bio-
hybrid device development, which could lead to a variety of technologies – including 
implantable bio-hybrid organs and devices as well as remote bio-hybrid robots. 
Despite this potential, electro-genetic control has not garnered popular attention, with 
previous such work relying mainly on non-specific effects on the entire E. coli 
transcriptome 113 and a mammalian electro-genetic control circuit (which will be 
described below) 114.  
 
Existing “bio-electronic communication”  
There is, of course, a significant body of literature that concerns itself with 
electron transport in cells. This includes transport of electrons between cells and 
between cells and external electrodes or other electro-active species. The articles 
sometimes have titles or descriptions of the advancements use the words “bio-
electronic communication”115,116.  Below we make the distinction between previous 





Electron transport between living (cells) and non-living sources is a topic that 
can fall under various areas of study. One such area that is also relevant to our 
research is that of microbial fuel cells (MFCs)117, where external electrodes are used 
to accept electrons from cells, thus driving an electric circuit and accomplishing some 
other goal. The goal is typically either the consumption of waste, the generation of 
useful chemicals or electricity by the cells, or the measurement of some metabolic or 
redox status of the cell that can be deduced from the current118-123. The electrons 
reach the electrodes through diffusible mediators (such as in our case), nanowires, or 
surface bound proteins124,125. Although wildtype bacteria are typically used, some 
have been engineered to enhance the process or to give more-easily-engineered E.coli 
additional functionality116,126. The main concerns in these technologies are the ability 
of the cells to store, transfer, and donate electrons (usually the species of bacteria 
used and its’ electron transfer mechanisms), the method of this interaction, power 
generation, and the stability of the electrodes and system over time, among others. 
Typically, genetic responses of the cells to the current or the various redox 
interactions are not investigated. 
In our work, since we utilize ferricyanide as an electron shuttle that interacts 
with the electron transport chain, we use some of the research principles, setups, and 
have some similar concerns as those of MFC studies, especially when investigating 
the metabolic effects of our system. An additional similarity with some of the above 
research lies in that essentially what we are doing is also drawing out electrons from 
the cells using the electrode, even though our goal is to put “information” into the 





ours is that we are not concerned with power, product, or current generation. We are 
concerned with using electronic control of redox molecules to activate a specific 
promoter sequence and elicit specific gene expression. In this, our method has more 
in common with research developing novel methods for precise spatio-temporal gene 
control such as discussed below. 
 
State of the art of externally-mediated biological gene control 
Typical cellular genetic control by an external inducer involves the addition of 
the inducing chemical to the cell culture media. Varying concentration and time of 
exposure can result in different cellular responses. Washing the cells, i.e. pelleting 
and re-suspending in inducer-free media, is one way to determine behavior related to 
a “burst” of induction. Another avenue that has been pursued for quickly varying and 
pulsing the concentration of inducer molecules is through the use of microfluidics. A 
variety of geometries has been implemented in order to allow alternating fluid flows 
with different inducer concentrations127-130. This, however, requires a lot of setup 
planning and equipment for pumping and controlling the fluid flow and making the 
channels and devices. Below, we summarize some additional methods that explore 
the use of stimuli that can be more easily regulated. 
 The past decade or so has seen a great push towards getting cells to recognize 
non-biological or non-native signals which can then be used to functionally or 
genetically control the cells. There are several benefits to this, including faster and 
more precise (both in terms of location and in terms of genetic elements) control, low 





basic research have been the end goals. Figure 4.1 shows some examples of using 
stimuli of non-native origin to control gene transcription. Light waves have been used 
in a variety of setups- one example being that which is described in Figure 4.1 a, 
where a light-controlled photo-caging group is released upon light illumination from 
a molecule, which can then bind to and de-repress a repressor, resulting in gene 
transcription 131. More commonly, light-responsive proteins expressed inside cells 
have been shown by many to induce gene expression or cellular behaviors in 
programmable temporal patterns and in a variety formats, including in live mice 132-
137. Protein engineering has been also used and has yielded cells that respond to light 
and produce NO to communicate to electrodes138. Light-driven genetic and behavioral 
control has grown into the field of optogenetics, and has even been used to wirelessly 
translate human thoughts to gene expression in mice139. 
In addition to light-mediated communication, in Figure 4.1 b is an example of 
an electrically-driven mammalian genetic circuit where the electrochemical oxidation 
of ethanol to acetaldehyde drives the production of the enzyme SEAP, whose product 
p-nitrophenolate can be optically detected 114. In Figure 4.1 c, we can see an example 
of a remote radio-controlled heating of nanoparticles resulting in calcium influx into 
the cell, which then results in the gene expression of insulin 140. Electronic control has 
also resulted in  the influx of calcium in neurons141. These are just some example of 






Figure 4.1: Novel modalities of gene control. a, Control over gene expression with 
photocaged small molecule inducers of transcription. The photocaging group is represented 
by a blue sphere and the small molecule inducer is represented by a red sphere. When the 
small molecule is caged, the repressor protein will bind the promoter PR. After UV irradiation 
the caging group is removed and the small molecule will bind the repressor, which releases 
PR, and allows for transcription to occur 131. b, Diagram of the mammalian electro-genetic 
device. DC applied to the input device results in the electrochemical conversion of ethanol 
into acetaldehyde, which enables the acetaldehyde-dependent activator AlcR to bind and 
induce transcription from the promoter PAIR, which triggers transcription of SEAP. SEAP 
subsequently catalyzes the production of colored p-nitrophenolate, which is quantified 
photometrically at 405 nm by a photodiode and converted into an electric output 
signal114.  c, Schematic of nanoparticle-induced cell activation and gene expression. 
Antibody-coated ferrous oxide nanoparticles bind to an epitope, His × 6, in the extracellular 
loop of the temperature-sensitive TRPV1 channel. Exposure to an RF field induces local 
nanoparticle heating, which opens the TRPV1 channels. Calcium entry triggers downstream 





translocation to the nucleus. There NFAT binds to upstream response elements to initiate 
gene expression of a bioengineered human insulin gene140.  
 
All of the above-mentioned stimuli originate from electronic devices whose 
signals we are able to easily control. The hope is to have more precise, localized, and 
remotely-activated stimulus control. These ingenious methods have either repurposed 
naturally-responsive proteins and wired them to behave in a novel way or 
implemented a combination of nanotechnology and genetic engineering to 
accomplish their goals. All methods are interesting and have roles in a variety of 
applications. As can be seem from the above, there has been some interest in using a 
more direct electronic stimulus, but finding the best method or intermediaries to use 
has proved challenging. Below we describe how redox molecules could be used to 
accomplish this goal.  
 
Redox reactions in the cellular context 
Cells are continually bombarded by a variety of redox-active molecules both 
from the external environment and those endogenously produced. There are many 
biologically-relevant molecules that have redox properties. Some, such as those that 
are part of the electron transport chain in cells, have very specific locations in the cell 
and standard potentials tailored to accomplish their tasks. They are well localized and 
their interactions are thusly contained. Other molecules are diffusible and more 
promiscuous in their interactions– superoxide, hydrogen peroxide and secreted redox 





There is a biologically-relevant class of redox molecules known as reactive 
oxygen species, or ROS. These molecules are often generated as byproducts of 
normal cellular metabolism or as a sign of a diseased state, and can be highly 
reactive. Because these molecules are often strong oxidants, they can wreak havoc on 
the cell by “stealing” electrons from a variety of components – damaging proteins, 
lipids, and DNA142. Since these molecules can result in oxidative stress, cells have 
evolved intricate mechanisms to combat it and bring the conditions back to normal. 
The OxyR and SoxR proteins, for example, are both part of E.coli’s natural oxidative 
stress response network143. They react with damaging redox molecules, such as H2O2 
and redox cycling drugs, and act to modulate cell genetic responses to mediate the 
damage and return to homeostatis. Our aim is to hijack one of these redox-responsive 
proteins to activate engineered genes and control desired cellular behavior. 
 
Pyocyanin and its genetic effects 
One redox molecule we propose to use for electrically-driven genetic control 
is pyocyanin (sometimes indicated as Pyo in figures in this chapter), whose structure 
can be seen in Figure 4.2 a below. Pyocyanin is a well-studied redox-cycling 
molecule that is secreted by P. aeruginosa and has a number of effects on the 
metabolism, community organization, and behavior of a number of bacteria144,145. 
Another important effect that pyocyanin has on many prokaryotic and eukaryotic 
cells is that of oxidative stress generation146. Although a complete model of the 
actions of pyocyanin still has to be elucidated, there is evidence that it enters non-





reduced flavins or metal centers of proteins147,148. If re-oxidized, it can generate 
superoxide radicals and hydrogen peroxide and continue its cycling behavior to 
increase oxidative stress inside the cell147.   
Although high concentrations of pyocyanin are toxic due to the oxidative 
stress they create, the molecule has also been shown to act as an extracellular electron 
shuttle in cases of oxygen limitation and in microbial fuel cells149. Additionally, our 
work with pyocyanin has shown that it is reduced by E.coli cells in growth media and 
in anaerobic conditions extracellular pyocyanin remains in the reduced form until re-
oxidized either by oxygen or an electrode150.  
To use pyocyanin as a gene activator, we used the specific regulon system that 
responds to it, the SoxRS regulon144,151,152. It is one of the best characterized redox-
responsive systems in bacteria, and its workings and effects can be seen in Figure 4.2 
b. In E.coli, it consists of the SoxR and SoxS proteins. SoxR is an iron-sulfur cluster 
protein that is usually maintained in an inactive form while its clusters are in the 
reduced state. Upon the oxidation of the clusters through the actions of redox-cycling 
drugs, SoxR changes its conformation. This results in the transcription of the SoxS 
protein from the soxS promoter151.  
 
 
Figure 4.2: Pyocyanin and SoxRS operon. a, The chemical structure of pyocyanin. b, 





oxidation, the SoxS gene is transcribed from the soxS promoter. SoxS then starts the 
transcription of a variety of genes involved in DNA repair, metabolism, and detoxification. 
 
The SoxS protein then activates the transcription of a few dozen genes, 
including those involved in DNA repair, detoxification, central metabolism, and 
maintaining cellular reducing power153. It has previously been hypothesized that 
redox-cycling drugs, such as pyocyanin, activate SoxR indirectly by first reacting 
with oxygen and producing the superoxide radicals that then activated SoxR154. 
Recently, Gu and Imlay have shown convincingly that it is not superoxide but rather 
the redox cycling drugs themselves that directly cause the activating conformational 
change of SoxR. Menadione, phenazine methosulfate, methyl vialogen (paraquat) and 
pyocyanin are examples of drugs that were shown to have this effect on the SoxRS 
system155. The role of oxygen in the activation is that of recycling the drugs to the 
oxidized state either directly or through the electron transport machinery. Once the 
drug is cleared, the SoxRS system returns to its inactive state through the action of 
NADPH-dependent reductases which reduce SoxR156. Thus the SoxRS regulon, 
activated by pyocyanin, presented us with a genetic element to implement in our 
system. 
Initially, our thought was to use only pyocyanin as a redox mediator and to 
control its oxidative form with an external electrode and thus control expression from 
the soxS promoter. Since it has been shown in literature 157 as well as in our work150 
that oxidized pyocyanin can be electrochemically reduced and re-oxidized, the 
process theoretically allows us to control the specific amounts and timing of oxidized 





SoxR and activate reporter genes under the soxS promoter. Using pyocyanin to shuttle 
electrons from the electrode to the cell and to the SoxR protein to activate 
transcription in this way would allow us to explore this strategy as a possible spatio-
temporally precise way for controlling genetic switches. Many of our initial 
experiments showed, however, that the pyocyanin-only induction from the soxS 
promoter was not consistently and significantly high enough at low-enough 
concentrations anaerobically. The reasons for this and the additional components we 
introduced to the system are described below. 
 
Anaerobic respiration in E. coli 
One of the most important processes where electron transfer plays a major 
role inside the cell is during metabolism in the electron transport chain158. In both 
aerobic and anaerobic conditions, E.coli cells express proteins and enzymes 
depending to the electron donors (fuel) and acceptors present159. Although we do not 
present an exhaustive review of E.coli metabolism here, this section will explain 
briefly the processes that are relevant to our studies. 
E.coli are facultative anaerobes – meaning they prefer to grow with oxygen 
but can do so without it by expressing different proteins to take advantage of 
available alternative electron acceptors. The substrate-dependencies, machineries and 
pathways are well-documented for E.coli, a representation of which can be seen in 
Figure 4.3 below.   
In most studies that describe the use of E. coli for applied processes, sugars 





phosphorylated using different mechanisms, depending on the sugar. Here we will 
use glucose as an example. The glycolysis pathway, located in the cytosol, processes 
the phosphorylated glucose into two molecules of pyruvate, which is accompanied by 
the release of a net of two ATP and two NADH molecules.  
Under aerobic conditions, pyruvate is then converted to acetyl-CoA and 
carbon dioxide. Acetyl-CoA is further processed within the TCA cycle, which 
produces more ATP and NADH. The NADH is then used in the respiratory 
machinery to create a proton gradient, which drives the production of more ATP 
through ATP synthase. Aerobic electron transport chains contain a dehydrogenase 
enzyme, which oxidizes an electron donor such as NADH, and a cytochrome oxidase 
that reduces O2 to H2O with the electrons from the donor. Ubiquinone acts as the 
electron carrier between the enzymes. Cytochrome oxidases can be made with 
different affinities for O2, ability to pump protons, cytochrome content, and gene 
expression profiles. Each of the cytochrome oxidases can receive electrons from 
various alternative electron-donating dehydrogenases. This allows E. coli to grow 
under aerobic and microaerophilic conditions. It is important to note that both aerobic 
and anaerobic respiratory chains are modular, with different enzymes produced 
depending on the conditions or donors/acceptors present.  
When oxygen is not present, cells switch into anaerobic respiration or 
fermentation mode depending on whether and which electron acceptor molecule is 
present. Electron acceptors include nitrate, nitrite, DMSO, TMAO, and fumarate, 
among others160,161 (we discuss below that ferricyanide has been shown to act as an 





regulated, which leads to an incomplete oxidation of the sugars. Different 
dehydrogenase and reductase enzymes (used here instead of the oxidase enzymes) are 
expressed to allow electrons from the available donors to reach the available 
acceptors (see inset table in Fig. 4.3 below). Here menaquinone is typically used 
instead of ubiquinone to transport electrons. Depending on available acceptors the 
number of electrons transferred differs and the cell is able to gain a specific number 
of ATP molecules through the respiratory processes resulting from the proton 
gradient or substrate level phosphorylation/fermentation. 
When suitable electron acceptors are unavailable in anaerobic conditions, 
E.coli uses fermentation to produce the ATP it needs to function. It is known that 
acetate accumulates during anaerobic respiration162 but under fermentative 
conditions, a mixture of various metabolites such as succinate, formate, acetate, 
lactate, carbon dioxide, hydrogen, and ethanol are produced to maintain redox 
balance163. After glucose is broken down to pyruvate via glycolysis and ATP and 
NADH are released, the NADH must be re-oxidized to NAD+ to support further 
glucose metabolism by the cell. These oxidation steps are accomplished by reducing 
several of the intermediates (such as pyruvate or a derivative product), which results 
in the formation of the “mixed acid” fermentation products.  
In our experiments, we grew cells in mostly anaerobic conditions, though 
some aerobic experiments were also performed. The availability and type of fuel, of 
course, also determines the rates of growth of the bacteria, the movement of electrons, 
and the production of proteins, including reporter proteins. Additionally, it is 





of cells producing significant amounts of recombinant protein – affected the growth 
of our cells79. 
 
Figure 4.3: Schematic overview of metabolism and respiration in E.coli. 
Schematic showing the metabolic reactions involving glucose – glycolysis, TCA cycle, and 
mixed acid fermentation (dark blue dashed arrows). If the appropriate electron donors and 
acceptors are available (insert table) then either aerobic or anaerobic respiration can take 
place (purple dashed boxes).  Some of the ATP synthesis through substrate-level 
phosphorylation is indicated in green text, along with NADH and other products. ATP 






Ferricyanide as an electron acceptor 
 Ferricyanide and ferrocyanide, oxidized and reduced forms of the same 
molecule (sometimes indicated as FCN3 and FCN2 in figures in this chapter), are 
used as a common reference redox couple in electrochemical experiments. The 
standard potential of the couple is about +0.25 V in the buffered system that we 
employed164. The molecule has been commonly used in biochemical oxygen demand 
(BOD) and toxicity165 testing of microbial cultures, as ferricyanide can act as an 
electron acceptor by interacting with the electron transport chain (Figure 4.4 ) 166-169. 
Upon accepting electrons, the reduced ferrocyanide exits the cell and can be 
quantified, either spectrophotometrically or electrochemically. The rate of 
ferricyanide reduction is then used to calculate the metabolic activity of the culture or 
toxicity of any chemicals tested. The molecule is said to not enter the cytosol of the 
bacteria or interact with any genetic or cytosolic elements. It has also been used as an 
electron shuttle in microbial fuel cells170 and as an indicator for internal redox 
activity121, as it “samples” the electron transport chain without being toxic. 
 Although there has been use of ferricyanide as a microbial electron acceptor, 
there is still not a great amount of evidence as to which elements of the electron 
transport chain it interacts with. Some studies indicated that ferricyanide interacts 
with members of the nitrate respiratory system171 while others suggest that thiol 
groups in general play a role172. Studies have also shown that ferricyanide promotes 
ATP generation in E.coli through substrate level phosphorylation173 instead of 





of electron carriers in the chain. In Figure 4.4 c we show the standard potentials of 
various dehydrogenases, reductases, oxidases, and the quinones of the E.coli electron 
transport system. Pyocyanin and ferri/ferrocyanide are also included to demonstrate 
which components they are most likely to interact with.  
 
 
Figure 4.4: Standard potentials of electron transport machinery. a, Chemical 





ferricyanide and the respiratory chain of microorganisms. The reduced ferricyanide can then 
be recycled back to the oxidized form at an electrode.  c, The standard potential of the 
majority of E.coli dehydrogenases, reductases, oxidases, and quinones. Pyocyanin and 
ferri/ferrocyanide are also included to demonstrate the potential for redox interactions with 
the enzymes. Data is mostly from Unden and Bongaerts.  
 
 Ferricyanide addition to anaerobic cultures has been shown to increase growth rate, 
which is proportional to the amount of reduced ferricyanide174,175.  The more recent 
application-driven research utilizing ferricyanide as an electron acceptor do not 
postulate on or present specific sites where it may be reduced. Although locating the 
site of ferricyanide interaction was not part of our research goals, we did investigate 
the metabolic and growth effects of both ferricyanide and pyocyanin on our cells in 
order to shed more light on the functioning of the system. 
 
Ferricyanide effect on redox cycling drugs and SoxR  
Gu and Imlay144 showed that adding ferricyanide to an anaerobic culture of 
bacteria sensitizes them to the effect of redox cycling drugs, of which pyocyanin is an 
example. Specifically, they saw that SoxR-driven β-galactosidase production was 
greatly increased in the presence of ferricyanide and phenazine methosulfate (PMS) 
than with PMS only. They hypothesized that the ferricyanide acted as an electron 
acceptor and drew electrons through the electron transport chain. The PMS interacted 
with SoxR, oxidizing it and becoming reduced itself, and then donated electrons into 
the electron transport chain, becoming re-oxidized, and continuing to oxidize SoxR 





PMS-electron-transport-chain cycling and amplified gene expression. In this paper, 
Gu and Imlay put forth that oxygen’s role in amplifying the response to redox cycling 
drugs is to cause re-oxidation of the drug internally and that ferricyanide was acting 
in a similar manner. Based on this data, and after performing our own preliminary 
studies, we decided to utilize this mechanism to use electrochemical control of 
ferricyanide form to drive pyocyanin-induced gene expression in anaerobic 
conditions.  
 
phiLOV- an anaerobic fluorescent protein 
Anaerobically-respiring E.coli grow slower than when oxygen is present, and 
produce any oxygen-dependent proteins much slower or not at all. This unfortunately 
includes many of the commonly-used fluorescent reporter proteins such as GFP, for 
which oxygen is needed for the fluorophore to mature176. Thus for our experiments, 
without oxygen, an anaerobic reporter was needed to track the response of the cells. 
We use an engineered anaerobic fluorescent protein with an FMN cofactor that does 
not require oxygen to produce fluorescence. The protein is called phiLOV 177, and is a 
genetically-enhanced iLOV fluorescent protein taken from Arabidopsis 
thaliana phototropin 2. Additional benefits of phiLOV include its pH stability (4-
9)178, and small size (112 bp). A degradation tag was put on the protein to allow it to 
degrade in the absence of the inducing signal (or in the absence of enough inducing 
signal). This allowed us to use time-variable induction and measure the correlated 
responses. Additionally, this would allow us to balance inducing with non-inducing 






Dynamic reporter engineering 
 In order to achieve quick protein degradation and subsequent oscillations a 
small amino-acid tag, called an ssRA tag, is often used to mark the protein for 
degradation. Naturally, ssRA tagging occurs when a ribosome encounters and gets 
stuck on a broken mRNA. Without the normal termination codon, the ribosome then 
cannot separate from the malfunctioning mRNA. A special type of RNA known as 
ssRA (small stable RNA A) saves the ribosome by the addition of an eleven-codon 
degradation tag followed by the stop codon. This allows the ribosome to break free 
and continue its normal job. The tagged, incomplete protein then gets degraded by the 
proteases ClpXP or ClpAP. The original ssRA tag had the 
sequence AANDENYALAA179, but additional tags have been engineered which 
result in different half-lives of the proteins180. Several recent studies have used this 
degradation tag on fluorescent or regulatory proteins and have achieved numerous 
complete oscillations of the fluorescent proteins with one to two-hour cycles 13,181,182. 
Here we utilize the ssRA tag AANDENYADAS for fast degradation of a number of 
proteins, as stated in the text, to achieve dynamic response.  
Materials and Methods 
Chemicals and Biocomponents 
Potassium ferricyanide (III), potassium hexacyanoferrate (II) trihydrate, 
parafolmaldehyde powder, propidium iodide, pyocyanin ready-made solution from 





phosphate buffered saline tablets were from Sigma Aldrich. LB broth, Miller, Agar, 
KCl, and casamino acids were from Fischer scientific. M9 medium consisted of 1 x 
M9 salts, 0.4 % glucose, 0.2 % casamino acids, 2 mM MgSO4, and 0.1 mM CaCl2. 
For in situ electrochemical control 100 mM MOPS was also added.  M9 salts were 
made according to common recipes from components purchased from Fischer 
scientific.  
 
Electrodes and Electrochemical Setup 
For bulk electrolysis we used 50 cm-long gold electrodes from Alfa Aesar 
(0.5 mm diameter, 99.95 % metal basis) wound to increase surface area. Ag/AgCl 
reference electrode was from BASi. For measurement purposes, an Au working 
electrode with 2 mm diameter, CH Instruments, Inc. was used. A CHI 600-series 
potentiostat was used for all electrochemical experiments.  
Agar salt bridges were made by bending a 6 inch –long 1.2 mm OD, 0.9 mm 
ID glass capillary tube (from World Precision Instruments, Inc.) using a Bunsen 
burner. A 3 % agar solution with 1M KCl was heated and added into the u-shaped 
capillary tube. This was then cooled by immediately immersing in a 3 M KCl 
solution. The bridges were stored in 3 M KCl in 4 °C. 
For bulk electrolysis, oxidation in this chapter indicates a constant application 
of +0.5 to +0.51 V and reduction -0.3 to -0.29 V. Typical electrochemical setup for 
bulk electrolysis and in situ experiments was as following: Working electrode and 





filled). In a separate similar vial was the counter electrode with another 3mL of 
solution. Two salt bridges linked the two chambers. A mini magnetic stirrer from 
Fischer Scientific with a 7 mm stir bar was used to facilitate mixing and accelerate 
electrochemical conversion in both vials.  
 
Establishment of Anaerobic Conditions  
A Coy anaerobic chamber was used in order to maintain anaerobic conditions. 
It was set up as per manufacturer’s instructions and Nitrogen + CO2/H2/N2 mix was 
used to maintain anaerobic conditions. 
 
Cell Strains  
The majority of the experiments used the E.coli cell line DJ901 (Δ lacU169 
rpsL ΔsoxRS90) 183 or GC4468 (Δ lacU169 rpsL) 184. For cloning the cell lines 
NEB5α (New England Biosciences) and Top10 Chemically Competent 




Before beginning of experiments, cells were grown in LB media in 37C in 
aerobic conditions with 250 rpm shaking until early or mid-log phase (OD600 0.25 – 
0.5). For anaerobic experiments the cells were spun down and re-suspended in M9 
glucose casamino acids media, unless otherwise stated, and then taken into and grown 







E.coli cloning was done according to standard molecular techniques 185.  
The SoxR-soxS DNA region was amplified from the E.coli MG1665 genome using 
the primers indicated in Table S4.Z and ligated into the TOPO plasmid. The SoxR-
soxS fragment was then digested out with the BamHI and HindIII enzymes and 
ligated into a similarly-digested pBR322 vector. The phiLOV protein was produced 
as a gBlock by IDT (sequence in Table S4.1). The pBR322-SoxR-soxS-phiLOVand 
phiLOV-LAA plasmids were assembled using the Gibson Assembly method 186 by 
PCR-ing both the phiLOV protein (with or without the tag) and the pBR322-SoxR-
soxS constructs with the appropriate overlaps using the primers in Table S4.1. The 
DAS tag was added to the phiLOV protein in the assembled plasmid by PCR-ing the 
whole plasmid with the LAA tag with the primers in Table S4.1, treating the PCR 
with T4 polynucleotide kinase and ligating with T4 ligase. The relevant genetic 
element sequences can be found in Table S4.2. 
In all cases DNA was extracted from cells using either a Qiagen or a Zymo 
Research Miniprep kit according to manufacturer’s instructions. Polymerase chain 
reaction (PCR) was used to amplify genes or DNA of interest using Q5 DNA 
Polymerase (New England Biolabs, NEB). Primers were ordered from Integrated 
DNA Technologies (IDT). NEB restriction enzymes such as BamHI and HindIII were 
used to generate restriction digests of desired PCR products or plasmids. Agarose gel 
electrophoresis was used to separate  DNA fragments based on size and the gel bands 





DNA Sequencing Facility was used to verify the constructs. Digested fragments were 
ligated using either NEB Quick Ligase or NEB T4 Ligase. Gibson Assembly was 
performed with NEB’s Gibson Master Mix according to manufacturer’s instructions. 
Electro- or chemically-competent cells (either from NEB, Invitrogen or made 
competent with Zymo Research’s Z-Competent E.coli Transformation Kit) were used 
for transformation.  
 
Cell Fixing 
Cells were washed and re-suspended in 0.1M Phosphate Buffered Saline 
(PBS) of pH 7.1 (from tablets). The cells were then fixed with an equal volume of 
chilled 4% parafolmaldehyde in PBS (pH 7.1) for 30 min at room temperature. 
 
Spectrophotometric Reading 
An M2 spectrophotometer was used. To detect absorbance of ferricyanide a 
420 nm wavelength was used. To detect cell OD, a 600 nm wavelength was used. In a 
96-well plate, volumes varied between 100 – 200 µl, but all compared samples were 
of the same volume. The OD600 was then converted to a cuvette-equivalent using the 
spectrophotometer manufacturer’s suggested conversion and measured standards.  
 
Flow Cytometry 
Flow cytometry was performed by a BD Biosciences FACS Canto with the 





measured with the flow cytometer. To ensure sample consistency, 50,000 cells were 
collected for each sample and consistently gated by forward scatter (FSC) and side 
scatter (SSC). The mean green fluorescence levels (set to measure FITC fluorescence) 
are based on the means from the number of indicated samples, and analysis of the cell 
population was done in FACSDiva and Excel.  
 
Propidium Iodide Staining 
Propidium Iodide was used to stain dead bacteria. After the treatment, cells 
were washed in 10mM MgSO4 (pH 6.5), then PBS, and finally re-suspended in PBS 
with 5 µg/ml of PI added. The cells were incubated at RT while covered with foil. 
Afterwards, they were resuspended in PBS and measured with FACS as above, 
except the excitation and emission were set for DsRed measurement. 
 
Glucose Measurement  
Glucose measurements in the media were done using a YSI 2700 bioanalyzer. 
A standard dextrose membrane and a 2.5g/L standard solution were used. 










Results and Discussion 
Pyocyanin and ferricyanide-dependent gene induction from the soxS promoter 
 We first investigated the induction of the phiLOV fluorescent protein from the 
soxS promoter in response to the addition of pyocyanin and ferricyanide. Our 
hypothesis is that pyocyanin interacts with the SoxR protein and oxidizes it, which 
results in phiLOV protein production (Box 2 in Figure 4.5). Ferricyanide interacts 
with the cell by acting as an electron acceptor for one or more parts of the electron 
transport machinery (Box 1 in Figure 4.5). Ferricyanide can be re-oxidized from 
ferrocyanide by an extracellular electrode. Together, pyocyanin and ferricyanide 
added to cells amplify the response from the soxS promoter through the interaction of 
pyocyanin with the electron transport chain as it donates electrons into the chain. 
Ferricyanide allows this process to amplify as it provides an electron sink. These 
processes work anaerobically since oxygen interacts both with the electron transport 
chain and with pyocyanin (by oxidizing it). 
 
Figure 4.5: Schematic of ferricyanide-driven amplification of pyocyanin-





the components that allow ferricyanide to interact with the electron transport machinery 
(general representation by colored rounded squares) of E.coli as an electron acceptor. 
Electronic recycling of the oxidized FCN3 form allows this process to be controlled. Box 2 
represents the oxidation of the SoxR protein by pyocyanin and the subsequent protein 
production. The functioning respiratory chain (with the electronically-controlled ferricyanide 
as the acceptor) works to re-oxidize the pyocyanin and amplify the response from the soxS 
promoter.  
 
 We began testing our hypothesis by growing DJ901 cell containing the 
pBR322 SoxR-soxS-phiLOV plasmid anaerobically in M9 glucose media in the Coy 
Chamber. Increasing concentrations of pyocyanin added to the culture resulted in 
higher phiLOV production as measured by FACS (Fig. 4.6 a insert). The addition of 5 
mM of ferricyanide amplified protein production to a much higher degree than just 
increasing pyocyanin concentration (up to 17-fold in the case of 5 µM of pyocyanin) 
(Fig. 4.6 a). Varying the concentration of ferricyanide also changed the amount of 
protein produced (Figure 4.6 b), and when the degradation tag –DAS was put onto 
phiLOV and protein production was measured over time, increasing ferricyanide 
resulted in a higher protein amount over a longer period of time (Figure 4.6 c and d, 
pyocyanin was 5 µM of pyocyanin). Negative controls of ferrocyanide or ferricyanide 
only were also tested, and as can be seen from Figure 4.6 b, did not result in an 
increase of protein. Therefore, we concluded that pyocyanin and ferricyanide are both 
necessary for the increased protein production from the soxS promoter, with 






Figure 4.6: Pyocyanin and ferricyanide effect on fluorescent protein production 
from soxS promoter. a, Fluorescent protein production due to pyocyanin and  
amplification with the addition of 5 mM ferricyanide. b, Cell fluorescent response is 
concentration-dependent on ferricyanide that is added to 5 µM  pyocyanin and is not affected 
by ferrocyanide or ferricyanide alone. c, Fluorescent protein time profile with the same 
pyocanin (5 µM)  but different ferriycanide additions. Ferricyanide oxidation by cells results 
in fluorescence drop. d, Data from c averaged over time for each ferricyanide concentration. 
This takes the amount of protein produced and degraded over the experiment.  
 
We are able to measure ferricyanide reduction by cells to ferrocyanide 
spectrophotometrically at 420 nm (420 nm absorbance correlates with ferricyanide 
concentration, Supplementary Figure S4.1). A higher concentration of ferricyanide 





OD when used with the same ferricyanide concentration (Supplementary Fig. S4.2 d). 
Additionally, higher cell OD’s resulted in lower cell fluorescence (phiLOV 
production) than lower cell OD’s induced with the same pyocyanin and ferricyanide 
concentration (Supplementary Fig. S4.2 c), indicating that perhaps the diffusion and 
partitioning of the molecules is dependent on cell amount. For our further 
experiments we induced cells with starting OD’s between 0.2 and 0.4.  
In order to test the dynamics of the system we induced the same cells 
periodically with pyocyanin and ferricyanide for 1 hour and then with pyocyanin and 
ferrocyanide. We did this by spinning the cells down and re-suspending them in fresh 
media + inducers. As can be seen in Figure 4.7, when ferricyanide was present, 
protein production increased, and when ferrocyanide was present it decreased, 
presumably from the –DAS-driven degradation of the protein. This showed us that 
the switch of ferricyanide to ferrocyanide and back is enough to turn protein balance 
in the positive (ON) or negative (OFF).  Additionally, cells exposed to the cyclical 
treatment over time were still able to respond by producing protein.  
We further tested the timing of the system by varying the ON and OFF times 
from 15 to 90 minutes each. Figure 4.7 b shows that a variety of ON/OFF times can 
be used. The minimum to see a complete ON/OFF cycle seems to lie somewhere 
between 15 and 30 minutes, as that is how long is needed to switch the cells from 
mostly protein production to mostly protein degradation states. This can be seen from 
the fact that the 15 minutes of OFF does not seem to decrease the protein amount, 





protein degradation.  Additionally, this showed us that a 15 minute lag-time in 
response is expected in this in situ system.  
 
Figure 4.7: Ferricyanide/ferrocyanide cycling effect on cell response. a, Cycling of 
ferricyanide and ferrocyanide alone results in either increase or decrease of fluorescence, 
respectively. b. Cycling of ferricyanide and ferrocyanide for different lengths of time allows 
tuning of amplitude of response. After the  ½ cycle measurement, cells were re-suspended in 
the “OFF’ solution of ferrocyanide and pyocyanin for the rest of the cycle. 
 
Growth and metabolic effects of ferricyanide and pyocyanin 
 Since ferricyanide acts as an electron acceptor in anaerobic conditions, and 
pyocyanin can be toxic to cells, we wanted to check the metabolic and toxicity effects 
of our treatments. This included the measurement of cell growth, the reduction of 
ferricyanide (which indicates cell respiratory health), glucose consumption and 
propidium iodide staining of treated cells. To tease apart metabolic effects of our 
treatments vs. those due to protein production, we used both the DJ901 cells with our 
plasmid, and those without any plasmid. Additionally, the GC6648 cells, which are 





As can be seen in Figures 4.8 and 4.9 below, we first grew cells with various 
treatments over 8 hours in a 96 well plate and took both OD600 (cell growth) and 
OD420 (ferricyanide) measurements. Cells without plasmid show a slight decrease in 
growth rate with added ferricyanide, but a higher growth when both pyocyanin and 
ferricyanide are added. The same can be seen with the GC4468 cells.  
Cells with the plasmid show a slight growth decrease with ferricyanide as 
well, but due to high protein production with both pyocyanin and ferricyanide, show a 
marked decrease in growth rate when both are added – with the DJ901 cells showing 
a much more pronounced decrease than GC4468. The GC4468 cells do not have the 
genomic SoxR mutation that DJ901 do, and therefore have a higher native/starting 
defense against pyocyanin, showing a lower anaerobic fluorescent protein production 
than DJ901 (Supplementary Figure S4.4 b).  
The most interesting effects were that cells both with and without the plasmid 
show a higher ferricyanide reduction rate when pyocyanin is present than when it is 
not, even though the cells with the reporter grew slower. This is evident for both the 
DJ901 and GC4468 cells (Figures 4.8 b and 4.9 b). This is a consistent trend we saw 
throughout our experiments.  
The above could be due to the enhanced cycling of pyocyanin inside the cell 
due to ferricyanide, which further increases ferricyanide reduction. The recycled 
pyocyanin inside the cell oxidizes SoxR and drives further phiLOV production, or, in 
the case of cells without the plasmid, oxidation of other cellular components. The 
GC4468 have a slower rate of ferricyanide reduction, presumably because of their 





higher rate of its export from the cell). This is a phenomenon which we intend to 
investigate further prior to publishing the data.  
 
Figure 4.8: DJ901 cell growth and ferricyanide reduction.  a, Growth of DJ901 
cells, with or without the pyocyanin-induced phiLOV fluorescent protein, is affected by the 
addition of ferricyanide and pyocyanin. b,. The reduction of added 5 mM ferricyanide or 5 
mM ferriycanide and 5 µM pyocyanin by DJ901 cells with or without the pyocyanin-induced 






Figure 4.9: GC4468 cell growth and ferricyanide reduction.  a, Growth of GC4468 
cells, with or without the pyocyanin-induced phiLOV fluorescent protein, is affected by the 
addition of ferricyanide and pyocyanin. b,. The reduction of added 5 mM ferricyanide or 5 
mM ferriycanide and 5 µM pyocyanin by GC4468 cells with or without the pyocyanin-






Figure 4.10: Effect of ferricyanide and pyocyanin on glucose consumption. a, 
Glucose measurements from DJ901 cells with the pBR322-SoxR-soxS-phiLOV plasmid 
grown with the indicated treatments starting at OD600 = 0.25. b, Glucose measurements from 
DJ901 cells without plasmid grown with the indicated treatments starting at OD600 = 0.25. 
 
We measured the anaerobic consumption of glucose due to various treatments 
of both DJ901 cells with and without the plasmid. M9 media supplemented with 0.4% 
glucose and 0.2% casamino acids was used. As can be seen from preliminary data in 
Figure 4.10 a above, when the plasmid for phiLOV-DAS production is present, 
glucose consumption is slowed with the addition of both pyocyanin and ferricyanide, 
but not in the presence of one or the other alone. This could be due to the slowed 
growth of the cells as protein production is greatly increased (higher metabolic 
burden). This is corroborated by the fact that when the plasmid isn’t present, glucose 
consumption does not seem to depend on the added mediators.  
DJ910 cells with the philov-DAS plasmid were grown and induced with 
ferricyanide and pyocyanin in media with different glucose percentages, and not 





(Supplementary Figure S4.3 a). Additionally, cells grown in the same media 
aneaerobically were induced with pyocyanin and ferricyanide for an hour at various 
points of growth (and therefore after higher amounts of glucose were consumed) 
(Figure S4.3 b). Again, cells that were grown for shorter amounts of time in the same 
media responded with higher fluorescence, presumably due to cell amount, glucose 
left, pH, and other metabolites present. Finally, re-suspending the same pyocyanin 
and ferricyanide-induced cells with fresh media + mediators resulted in a linear 
increase of response, whereas keeping cells in the same media resulted in eventual 
protein degradation.  
 An interesting trend can be seen when looking at both glucose consumption in 
Figure 4.10 above and cell growth in Figure 4.8 above. The cells start out growing 
relatively at a steady rate, then slow down around the 2 hour mark, and pick up 
growth again at a steady rate around 3 hours mark. Although the experiments in 
Figures 4.10 and 4.8 were done with different starting cell OD’s (those in 4.8 were 
lower at the start than those in 4.10) and slightly differing conditions (plate format vs 
tubes, and microaerobic vs anaerobic), we hypothesize that it is due to the 
consumption of most of the glucose present around 2 hours that the cells’ growth 
slows down. Before this, the cells would secrete various other more reduced 
compounds such as acetate or other mixed acid fermentation by-products. The end of 
the glucose supply would signal to the cells to switch their metabolism and utilize 
these more reduced compounds.  
 As stated in the introduction, previous studies have suggested that growth of 





production of acetate, which is a reduced compound and a result of fermentation. In 
these cases, it is among other products which signify higher energy production 
through substrate level phosphorylation rather than by respiration.  
 We have recently started the above experiments and plan on further 
investigating cellular production of acetate and other metabolic intermediates and 
products such as ATP in cells treated like those above. We hope to shed more light on 
the metabolic effect of the pyocyanin + ferricyanide combination and included the 
preliminary results above to demonstrate its importance. This would allow us to better 
tailor the experimental conditions (specifically, media composition) to achieve our 
desired result and responses from the cells.  
 Next, to further verify that it is because ferricyanide is acting as an electron 
acceptor that it amplifies the production of pyocyanin-induced protein, we used an 
alternative electron acceptor in a similar experiment with pyocyanin. As can be seen 
in Figure 4.11 below, nitrate, a common anaerobic electron acceptor, also results in 
an increase in phiLOV production when pyocynin is added. Nitrite, however, does 
not result in as high an increase in protein production, as it is the reduced form of 








Figure 4.11: Effect of nitrate and nitrite, electron acceptors, on cell response to 
pyocyanin treatment. Fluorescence of cells producing the phiLOV protein in response to 
5 µM added pyocyanin and the indicated concentrations of either nitrate or nitrite. 5 µM Na 
Myolobdate was added to all samples. 
 
 Our system is concentration-dependent on both pyocyanin and ferricyanide 
anaerobically, but when oxygen is present, as can be seen in Supplementary Figure 
S4.4, it is not. When any pyocyanin is present, oxygen amplifies the response in both 
GC4468 and DJ901 cells, and the concentration of ferricyanide (or even its presence 
as opposed to that of ferrocyanide) does not influence the amount of phiLOV. This is 
not to say that ferricyanide is not reduced by cells even when oxygen is present or 
doesn’t act in part as an electron acceptor, but it is probably that the protein 
production machinery is maxed-out in this state and/or oxygen is favored as the 
electron acceptor. In Supplementary Figure S4.4 b we can see that GC4468 cells 
respond with a lower amount of fluorescence when in anaerobic but not aerobic 






Electrochemical control of ferricyanide and pyocyanin redox state 
 To introduce electronic control of gene expression we needed to be able to 
have good control of the electrochemical state of the ferricyanide/ferrocyanide 
couple, as this would result in either an ON or OFF state of protein production. Using 
a three-electrode setup and a potentiostat we were able to easily perform cyclic 
voltammetry and chronoamperometry measurements to both determine the 
concentration and the redox state of the molecules (Supplementary Figure S4.5). 
Using bulk electrolysis and a salt bridge, as described in the Methods section, we 
were able to start with ferrocyanide in the working-electrode-compartment and 
ferricyanide in the counter and switch the redox state of both back and forth over 
several cycles without degrading the molecules or generating any interfering species 
(Figure 4.12). This confirmed to us that we would be able to oxidize and reduce the 
molecules back and forth successfully in media and that they may retain their effects 
on the cells and phiLOV production.  
 
 
Figure 4.12: Continuous oxidation and reduction of ferro/ferricyanide. a, 





in the working and counter chambers. Higher charge indicates a longer time of oxidation or 
reduction. b, cycling of the reduced/oxidized form of the ferro/ferricyanide couple in the 
same chamber shows no destruction of the electrochemical or absorption properties.  
  
To test this, we repeatedly oxidized and then reduced the same solution of 
media + mediators and saved these in aliquots on ice. At the end of the cycling, we 
added the saved media + either oxidized or reduced mediators to spun down DJ901 
pBR322 SoxR soxS phiLOV-DAS cells for 1.5 hours before fixing and measuring 
fluorescence with FACS. Figure 4.13 below shows that the cells responded in a 
predictable way, generating higher amount of protein when ferricyanide was present 
and less when ferrocyanide was present, even after the molecules were redox-cycled 
several times. These results allowed us to be confident that in further experiments, 
which would involve in situ ferricyanide reduction and oxidation, the redox cycling 
would have the desired effect on the cells.  
 
Figure 4.13: Cell response to electrochemically-oxidized or reduced mediators. 





pyocyanin, and 5 mM ferrocyanide that was either fully oxidized or reduced the indicated 
number of times.  
  
It’s important to note that we did not observe any chemical or electrochemical 
interactions between pyocyanin and ferricyanide, in either redox form. Though it is 
possible that one may oxidize or reduce the other, these interactions did not have any 
effect on our experimental results. When a ferricyanide + pyocyanin solution is 
reduced, we presume that the pyocyanin is reduced as well. However, reduced 
pyocyanin inside the cell can be re-oxidized somewhat even without ferricyanide, as 
we showed earlier. Therefore, we concluded that reduction of ferricyanide + 
pyocyanin solution and its effect in reducing protein production is largely due to the 
reduction of ferricyanide rather than pyocyanin.  
 
Electronic In situ control of protein amount  
After confirming that the electrochemically-cycled ferricyanide/ferrocyanide 
result in different rates of protein production, we decided to test an in situ system, 
with the cells already in the media with the redox molecules (5 µM pyocyanin and 5 
mM ferrocyanide) . Our first experiments involved turning the system “ON” with 
various potentials, to confirm that a specific oxidizing voltage is required. We applied 
the indicated potentials all for 15 minutes. As can be seen below in Figure 4.14, 
potentials between -0.3 and +0.6 were used. The grey CV in the background of Figure 
4.14 a is that of ferricyanide, with the reduction and oxidation peaks labeled at R and 





current was at +0.22 V. We can see from Figure 4.14 a and b that applying voltages 
between -0.3 and 0 did not result in significant charge due to ferricyanide generation, 
and therefore cells did not fluoresce. Between 0 and +0.2V we see a steady increase 
in charge, absorbance of ferricyanide, and fluorescence of cells. This indicates that 
even though the potentials are not strictly oxidizing (not more positive than the 
oxidation peak), there is still some conversion of ferro to ferricyanide, and therefore 
an increased response from the cells. Potentials more positive than the E0 resulted in 
similar conversions of ferro to ferricyanide and therefore similarly high/maximum  
average fluorescence. These results confirmed to us that indeed there is a particular 
voltage that fully turns the cells “ON” (+0.22 V and higher), and another voltage that 








Figure 4.14: Potential step-up and control of gene expression. a. Various potentials 
(x-axis) were applied for 15 minutes to cells with 5 µM pyocyanin and 5 mM ferrocyanide. 
The indicated charge was measured/observed. Cells were then incubated for 3 hours, over 
which the indicated average fluorescence was measured at one hour intervals. The grey CV in 
the background indicates the reduction(R) and oxidation (O) peaks of ferricyanide. b. The 
resulting charge (also from a) as compared to the absorbance of the resulting ferricyanide 






We picked a potential (+0.5 V) that was much more positive than the 
oxidation peak, since it is possible that the peaks may drift over the course of the 
experiment (we’ve observed this before, and it is based on the pH of the media), and 
applied various charges, ie. by electrochemically oxidizing 5 mM ferrocyanide and 5 
µM pyocyanin for various lengths of time, and therefore turning only portions of it to 
the ferricyanide form. As can be seen in Figure 4.15 a, the resulting average 
fluorescence is proportional to the charge of the oxidation reaction. The fluorescence 
is an average of several measurements taken over time, all of which can be seen in 
Figure 4.15 b. These results corresponded well with the trends seen when different 







Figure 4.15: Fluorescent response to various charges. a, Average cell fluorescence, 
phiLOV-DAS produced in response to the indicated charge, which turned part of the 5mM 
ferrocyanide + pyocyanin from reduced to oxidized form. b, A subset of the actual 
fluorescence FACS measurements from cells activated with the indicated charge, over time. 
Lower charges resulted in less conversion of ferro to ferricyanide and therefore lower 
response over time and quicker degradation. 5 µM pyocyanin is used for all samples. 
 
Additionally, we performed negative controls where the oxidizing and 





current was run with the oxidized molecules and the reducing current with the 
reduced molecules. This was done to rule out any genetic response to the current 
itself or other electrochemically-related unknown factors. Supplementary Figure S4.6 
shows that there was no response unless ferricyanide and pyocyanin were present in 
the oxidized form, and no unanticipated response from the currents themselves 
occurred.  
 
In situ response to ON/OFF cycling 
Next, we investigated whether ON/OFF cycling can also be accomplished in 
situ. Our first experiments involved a similar idea to Figure 4.6 above, with the 
application of one ON and one OFF voltage for various amounts of time. As can be 
seen in Figure 4.16, we saw a similar response to when the ferri/ferrocyanide was 
changed in the media in Fig. 4.6. However, we do see a longer delay in the OFF part 
of the cycle, due to the fact that it takes about 15 minutes for the ferricyanide to 
completely turn into ferrocyanide, during which time the protein is still presumably 
made, at a higher rate than it would be if the media was just exchanged and the 







Figure 4.16: In situ electrochemical cycling effect on response. a, Electrochemical 
actuation – 1/2 cycle of ON and then OFF. Cells were initially in the OFF state, and turned 
ON at time zero. After the ½ cycle measuremnt, the voltage was turned from ON back to 
OFF, electrochemically. Each half of the cycle was of the indicated time length. b,  The 90-
minute series shown here with the charge traces. The green and red curves represent 
accumulated charge. Green is during the ON phase (oxidizing +0.5 V applied) and red is 
during the OFF phase (reducing -0.3 V applied).  
 
In order to apply multiple cycles to the same cells, we chose 1 hour for each 
part of the cycle (ON 1 hour, OFF 1 hour), which would allow for sufficient protein 
production and degradation. Complete oxidation and reduction of the 5 mM 
ferrocyanide was accomplished within about 15-30 minutes. As can be seen in Figure 
4.17, we were indeed able to see increases and decreases in overall protein based on 
whether the ferrocyanide was oxidized or reduced previously. The actual charge 
traces can be seem above the graph in Figure 4.17 as green (ON) or red (OFF) lines. 
These show that the first 15 minutes have a linear oxidation/reduction and much 








Figure 4.17. Electrochemical ON/OFF cycling. Cell fluorescence as measured by 
FACS in response to cyclic ON/OFF electrochemical signals. The applied potential was 
either 0.5V (high, oxidizing, ON) or -0.3 (low, reducing, OFF). The green and red traces 
above indicate the resulting charge from the applied potential. Charge axes are 0 to -2 for ON 
(green) and 0 to 2 for OFF, similarly to Figure 4.16 above. Error bars represent standard 
deviation.  
 
In situ reactions over periods of time longer than about 6 hours, however, 
resulted in general fluorescence decrease and the inability of the cells to produce as 
much of a response as in the earlier timepoints. This is because over time, the growth 





all affected the ability of the cells to respond. Starting with a lower cell OD, and 
adding LB media with MOPS buffer instead of M9 media alleviated the problem of 
seeing consistent responses up to 6 hours, but for longer periods of time media 
exchange or some limitation on growth would need to be implemented (cell dilution 
perhaps). This can be achieved with the immobilization of cells on electrodes within 
microfluidic devices, and is described further in the Future Work section in the next 
chapter. We are currently pursuing these alternatives. 
 
Conclusions 
In this chapter, we have shown for the first time the use of a reversible redox 
molecule to control gene expression in bacteria with temporal accuracy. Although we 
are currently continuing the work and foresee a lot of improvements to the system, 
the investigations outlined above show that it is a viable method for providing bio-
electronic communication in the short term. The great benefits of our method are the 
direct translation of electronic to genetic signals (with a 15-30 minute lag time), the 
minimal additional genetic elements that need to be introduced to cells (SoxR protein 
and soxS promoter), the promising usefulness of the system in microelectronic-based 
lab-on-chip devices (location-specific response), and the low cost of the equipment 
needed to achieve electronic control. Overall this is a promising novel methodology 
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Supplementary Figure S4.1: Absorbance measurement of ferricyanide. 
Absorbance at 420nm can be used to measure ferricyanide concentration in the ranges used in 
this chapter.  
 
Supplementary Figure S4.2: Effect of cell OD and ferricyanide concentration on 
ferricyanide reduction and cell response. a, Ferricyanide reduction to ferrocyanide by 





b, Ferricyanide reduction by cells (the slopes from a) is concentration-dependent. c, Different 
cell ODs are reacted with the same pyocyanin and ferricyanide concentrations. d, Increasing 




Supplementary Figure S4.3: Fluorescent protein production with different 
glucose amounts. a, DJ901 cells producing the phiLOV-DAS protein in response to 5 µM 
pyocyanin and 5 mM Ferricyanide in media with different glucose concentrations. 100% 
signifies M9 media with 0.4% glucose (w/v). b, Cells were grown anaerobically starting at 
OD600=0.25 in M9 glucose CA media. After the indicated amounts of time, 5 µM pyocyanin 
and 5 mM Ferricyanide were added, and after an hour cells were collected for fluorescence 
measurement. c, Production of fluorescent protein continues when used media + mediators 







Supplementary Figure S4.4: Effect of aerobic conditions on ferricyanide and 
pyocyanin treatments. a, Fluorescence of cells producing phiLOV protein in response to 
the indicated treatments, aerobically. b,  Fluorescence of DJ901 or GF4468 cell producing the 








Supplementary Figure S4.5: Electrochemical ferri/ferrocyanide measurements 
and bulk electrolysis. a, Chronoamperometry of bulk oxidation of ferrocyanide to 
ferricyanide. b, Chronoamperometry of bulk reduction of ferricyanide to ferrocyanide. c, 
Maximum oxidation current measurements of various ferricyanide concentrations. d, 
Correlation between the 420nm absorbance and the maximum oxidation currents of various 






Supplementary Figure S4.6: Electrochemical negative controls. Cell fluorescence 
after 1 hour as measured by FACS (phiLOV-DAS) based on the indicated treatments. These 
are the electrochemical negative controls. 
 
Supplementary Figure S4.7: Propidium iodide staining of cells. Cells were grown 
with the various treatments for the indicated amounts of time and stained with propidium 








Supplementary Figure S4.8: Pyocyanin-only electrochemical oxidation. 






F: GGA TTT GGA TCC TTA GTT TTG TTC ATC TTC 
CAG CAA G 




F: GAC AGC TTA TCA TCG ATT TAT TAT TAC ACA 
TGA TCG CTG CC 
R: GAG GCA GAT TTA AGC TTA TGA TTG AAA 
AAA GCT TTG TGA TTA C 
pBR322-SoxR-I 
for Gibson 
F: AAG CTT AAA TCT GCC TCT TTT 
R: ATC GAT GAT AAG CTG TCA AA 
phiLOV-LAA 
for Gibson 
F: GAC AGC TTA TCA TCG ATT TAT TAT TAA GCA 
GCC AGA GC 
R: CCA GTG CAG GAG CTC TTA TTA TTA AGC 
AGC CAG AGC 
DAS tag 
addition 
F: TAG TTT TCG TCG TTA GCA GCC AC 
R: CGC TGA CGC TTC TTA ATA ATA ATA TCG 
ATG ATA AGC TGT CAA ACA TGA 
 
Table S4.1: Primers used for creating pBR322-SoxR-soxS-phiLOV and –






Genetic element Sequence 
LAA degradation tag GCT GCT AAC GAC GAA AAC TAC GCT CTG GCT GCT 
 




(adapted from Christie 
et al.177) 
ATG ATT GAA AAA AGC TTT GTG ATT ACC GAT CCG 
CGC CTG CCG GAT TAT CCG ATT ATT TTT GCG AGC 
GAT GGC TTT CTG GAA CTG ACC GAA TAT AGC CGC 
GAA GAA ATT ATG GGC CGC AAC GCG CGC TTT CTG 
CAG GGC CCG GAA ACC GAT CAG GCG ACC GTG CAG 
AAA ATT CGC GAT GCG ATT CGC GAT CAG CGC GAA 
ACC ACC GTG CAG CTG ATT AAC TAT ACC AAA AGC 
GGC AAA AAA TTT TGG AAC CTG CTG CAT CTG CAG 
CCG GTG CGC GAT CGC AAA GGC GGC CTG CAG TAT 
TTT ATT GGC GTG CAG CTG GTG GGC AGC GAT CAT 
GTG TAA 
 








Chapter 5:  Summary, innovations, and future work 
Summary 
 The dissertation presented here describes our work to facilitate bio-electronic 
communication. In Chapter 2 we showed that electronic signals can modulate the 
activity of the protein HLPT assembled on an electrode through the controlled 
oxidation of acetosyringone and the oxidation of residues on HLPT. To facilitate and 
explore electronic measurement of gene expression, we utilized the β-galactosidase 
reporter protein, whose reaction with the PAPG substrate yields the redox-active PAP 
molecule. In Chapter 3, we explored in-depth the relationship between this 
electrochemical method and the standard Miller assay – a first-time correlation which 
we hope will facilitate the use of the electrochemical measurement by synthetic 
biologists. Finally, in Chapter 4, we detailed the development of an electronic gene-
control system with the use of pyocyanin-induced soxS promoter and the 
electrochemical control of the electron acceptor ferricyanide. Overall, our 
developments make great strides towards promoting meaningful and facile bi-
directional communication between biology and electronics. 
 Our work has resulted in one published article, one article currently under 
review, and one in preparation. Additionally, the work has been presented at 5 







Electronic modulation of biochemical signal generation 
Innovation and contributions 
The study described in Chapter 2 provides the first evidence that direct 
electronic control of a diffusible redox mediator at the surface of a gold electrode in 
the vicinity of an immobilized enzymatic pathway results in predictable protein 
oxidation, attenuation of activity, and biochemical signal generation. In addition to 
HLPT, we demonstrated similar electronic activity control of two other enzymes’ 
activities (microbial transglutaminase and β-galactosidase). We also were able to use 
the redox couple Ir(III)/Ir(IV) with all three enzymes – further extending the utility of 
the technique. We envision that the novel suite of methodologies demonstrated here 




In the work described, the electrode used, attenuation setup, and incubation 
system were all macroscale systems. We believe that all of our techniques and steps 
could be translated easily into a microfluidic system with integrated electrodes. 
Several such systems from our group could be adapted for the task. We have 
previously shown the deposition of a chitosan film and enzymatic assembly of 
functional enzymes on that film in a microfluidic channel29,47. A third electrode could 
be integrated for the use as a reference electrode for attenuation reactions as well as 
real-time measurement of Hcy generation55. In fact, a fluidic application with flow 





limited to) (i) all gold or (ii) gold working and counter, with a silver reference. A 
variety of electrode geometries could also be used. 
 
Electrochemical detection of synthetic biology constructs – in situ β-
galactosidase detection in real time from whole cells 
Innovation and contributions 
Our results indicate for the first time that electrochemical measurement of β-
gal activity (cleavage of PAPG to PAP) in both lysed and intact cells is feasible as an 
alternative method to the gold-standard Miller assay. It enables added versatility for 
analysis of synthetic biology constructs, such as those exploiting lab-on-a-chip and 
other methodologies that benefit from real-time measurement. We demonstrated this 
by developing a biosensor bacterium that converts the signaling function of quorum 
sensing molecule AI-2 to electronic signals through a genetic (β-gal) and chemical 
(PAPG) transducer system. Our results showed that the electronic current measured 
was proportional to Miller Units from the same samples, and can be used to 
approximate gene expression in a multi-component synthetic circuit. Such 
electrochemical measurements allow for in situ analyte detection as they integrate 
seamlessly into electronic systems, and could therefore allow for programmable 
measurements of synthetic biology constructs. Additionally, we created a two-
compartment model that can be used to predict PAP (and thus electrochemical) output 
from our construct, and can be modified to accommodate other systems driving LacZ 
expression. We believe this work connects, for the first time, the work of the 





measurement techniques biologists use for the same purpose. A better link between 
synthetic biologists and biochip / microelectronics designers enables parallel use of 
each other’s’ tools and advances the potential for synergistic outcomes. 
 
Future work 
 We believe that the work presented in Chapter 3 in general can be used by 
synthetic biologists to analyze genetic circuits by electrochemical means. 
Additionally, the electrochemical measurement of gene expression presented here can 
be combined with the electrochemical gene actuation in Chapter 4 to create an bio-
hybrid system with both electronic inputs and outputs.  
 
 
Electronic control of bacterial gene expression through redox-driven 
transcriptional activation  
Innovation and contributions 
The method described in Chapter 4 is the first to use a reversible redox 
molecule to control gene expression in bacteria with temporal accuracy. It adds to the 
suite of novel genetic control methods that aim to provide precise spatio-temporal 
control. We have shown that our method (with the mediators used) does not 
significantly damage the cells. Our results showed that by manipulating factors such 
as mediator concentrations, cell amount, and culture conditions, different responses 
can also be elicited – adding a degree of customizability. Additionally, our metabolic 





The great benefits of our method are the almost-direct translation of electronic 
to genetic signals, the minimal additional genetic elements that need to be introduced 
to cells, the promising usefulness of the system in microelectronic-based lab-on-chip 
devices (location-specific response), and  the low cost of the equipment needed to 
achieve electronic control. Overall this is a promising novel methodology to translate 
electronic signals to genetic response that we intend to further develop and study. 
 
Future work 
In Chapter 4 is the first time our method has been described, and much work 
was put (and continues to be put) into validating the hypotheses of how the method 
works and what factors are important to elicit an optimal response. Some additional 
experiments will need to be performed in order to validate and strengthen our 
hypotheses and claims in the chapter, though we believe the data we presented is 
robust and convincing. We talk about those experiments throughout the results and 
discussion in Chapter 4. Here we present additional ideas that would expand on our 
method and utilize it in novel ways. We hope that much more can be done and 
demonstrated with our method, and some of this we have started working on.  
The true potential of our method, we believe, can be realized with cells that 
are immobilized in the vicinity in the signaling electrodes in such a manner that 
allows easy media flow and exchange and faster diffusion of mediators between cells 
and electrodes. As one of our limitations in terms of eliciting a strong response was 
the growth and secretions of the cells in situ, we believe cell immobilization would 
allow us to not only regulate the communication quicker, but also allow us to perform 





exchanging media easily. Depending on the reporters used, real-time responses could 
be measured, which would allow for a development of a closed-loop feedback-control 
system. We are currently working on developing a microfluidic platform that allows 
real-time detection of the fluorescent phiLOV response with a microscope from cells 
immobilized on gold electrodes within channels.  
Showing a phenotypic change due to genes being turned on and off using our 
method is another avenue we are pursuing. Already, we started experiments that aim 
to turn on both bacterial motility (with the CheZ protein187) and bacterial cell-to-cell 
communication (using the LuxI and LuxR system of quorum sensing [QS]188). The 
cell-to-cell communication will be especially beneficial as the “bio-electronics relay” 
cells, those producing LuxI and secreting the communication molecule in response to 
the electronic signals, will be the only ones that need to be in an anaerobic 
environment. Once the QS molecule is secreted, it can communicate the electronic 
signals to downstream sensor cells (those expressing LuxR) that can be in an aerobic 
environment. Additionally, an electrochemically-measured reporter, such as β-







Figure 5.1: Schematic of bio-electronic cells. Cells are producing luxI and AHL in 
response to electronic signals. The AHL diffuses to biosensor cells, which respond by 
producing a reporter, such as phiLOV, from the LuxI promoter. 
 
Additionally, in order to lessen the redox stress on the cells even further, the 
following can be implemented: To reduce the amount of pyocyanin and ferricyanide 
used, we can employ a genetic amplification mechanism (such as in Chapter 3) or an 
enzymatic reporter protein (including the above-mentioned LuxI and β-
galactosidase). We can up-regulate redox-scavenging enzymes during the times when 
the protein of interest is not being produced. Additionally, we can employ a different 
redox mediator (other than pyocyanin) that perhaps has less of an impact on redox 
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